var title_f32_58_33696="ERCP showing common bile duct stones";
var content_f32_58_33696=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F81598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F81598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ERCP showing common bile duct stones",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 445px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG9AbgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiop7mC3GbiaKIersF/nWdL4j0mMkG+iY+keX/lmgDWormbvxrpVvnAuJSP7iD+pFZkvxGslB8uxuWxzhiq/40WA7mivNpPijGHwulEj1Nxj/ANlpi/FPLhTo2M9/tX/2FOwHplFeeJ8TIyfm0tx9Jwf/AGWrMXxIsGYLJZXSn/ZKn+oosB3VFcrH470Vv9Y88X+/Hn+Wa0bbxRolyQItSgBPTedn/oWKQGzRUcE8U67oJY5F9UYEfpUlABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVj674l0rQ1P9oXiJJ2iX5nP4D+teda58UrmYtHo1ulunQSzfM35dB+tAHrM80VvE0k8qRRryWdgAPxNclrHxF0DTtyx3D3ko/ht13D/vo8flmvFNV1O/1Sbzb+7muXHI3tkD6DoPwrNYkZJ/lTsI9M1H4r30xK6bYw269N8pLt+XA/nXN3PjLXb2T/SdSuAueVjPlj6fLiuXDYIx1qTdnB707Ab32vMxaV2Zj1JbOa0NMuQ1ymCxHQ1zBcnbnrWtormOYHt9aANbUCTO4B4B/KqEpzG+evTrWhej96xA5+8OKzLiRUUg469PWgCpJHnkYJ681GCVIJ7cmnPIRj/OKjPCkkUAWFkDr14xyDViMkHJHU8VlFuBz0q7bOWfHX3oAsyyEtgDJHb0qNshwcECiXKuM8tnrT1w67fzoAWGeSGQGGR0cdCrYNdNp/ifWbUApeySKB92X5/51yyDBI5z6Va3FYxzxQB2Vj8TLiJ9mpWCOM43wsVP5HNdVYeONBu5BG94ttKcfJcfJ+vT9a8VYZkweTu71l+Iow+WB6daLAfUUUiSorxOro3IZTkGnV8j6RrutaJchtI1C4t+clA2Ub6qeD+Ven+HPjHNFsi8R2QcdPtFtwfqVP8AQ/hSsM9porI0DxHpOvwiTSr2KfjJQHDr9VPIrXpAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVDeXUFlbPcXcqQwIMs7nAFeReM/iufntvDwKJ0N04+Y/7oPT6mgD0rxB4l0zQYt1/cKJSMrCnLt+H9TXlHif4kalqO6HTc2NseMocyMP97t+FeZXOpz3Vw8txM8krnJdzkk+5oW7Ofm5NMRo3E7zO7SuXZuSxOSfqagaXB6/pUMV0hba+M+tSsoJUqQc0wFNwUYgD/69Ne5dsZx+WaGjO4kVGyjr2oAkWUk4xg96kRtwxg9etV1VsKBj61NCCWPIznt3oAtocqATWzp4Ixjjis+ytywI28jpnitm0jK5MhGPY0AaLOHjyByo61i3ozIB/CK1oRmNwemOazpY2aTI4HSgDOdT5nqDz1p+3d0FWPI+b5umPWpdgVCcH+dAFEw9zwO/arFquJF6YBphXc+Onf6VPbL82c4xwM0APuEG4ZpYE4JGetWpYg8SscfnzUUanbwOcH2oAFhy2WwvvRKB0zzjFN5AHHP8qGccA49PWgCsdwukP8HU4qvrUBYFh0POatX13HHGojBz/EcVX+0rPAyA54/SgDAit9pY4Bz3xSSQCUEbfzrQaNQTioynoBQBkKtzp9wk9rNJDKpysiNtI/EV6L4T+Leo6eUt/EEf223GB5y/LKv17GuLkhDcEZFZ11CU+7nbQB9VeHvEWmeILUT6VdJMP4k6On1XqK1q+PrC8vNNukubCeSCdTw6Ng17F4J+LaSlLPxOojfot2g+U/7w7fUUrDPX6Kjt5o7iFJoJEkicZV0OQR7VJSAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArmfGXjHTfC1tm6cS3bDMdsh+Y+59B71znxF+JEOiiWw0Zlm1HGGl6pCf6t7dB+leD395cX1zJc3cryzyNuZ3OSTTA2/GHjHU/El2Xu5SLcH93AvCJ+Hc+9cu7FicnNO7d800jjOaYhMHsaXcR3NNaigB4P1z9asQXLxsOQw7g1WGT60vbrQBqRXaM2Nm0+9Pzv46fSsvqR2NWIpccMTn3oAvKo4BGc+1TxZHIHeqsbA4z1q1FjIzx70AbWnuGC7sooHOO9XfMGPkxgjrWVbsMAE8j9KvQZK8HII4oAvxyE27AnBJprKCV6EHtS24wzEtn2Hahiu7KYB70AQsnrk+wqKXjjaStOuHIYqCapO5b356gUAPwxJyuPxqeFWB6gN3qqn1PSpU4IAzgUAbFud6ENz37GlW3AP3MHtzk1nqSAMZB+tSpNJtwGO7GMk0AE8YUE9Dn16VQmZdzbh9Bmrck+AQSST1Pqay5Zd7ngAUAQ3DZZgfums93eBiVOMcn3rQcjHv71TuVyAOp5oAdDdLJ1yG7rUxUMuVNZbIN2RwR6VNBctHw/K/yoAsOCpHcVDIueTVsssg3DvUbY9P0oAoS24OSg5rPnjKNyMVulR3qpeQeYpI+8KAOz+Efiu6029Ng0jyW0nSJjkA+3pXvNhfwX0e6FuR1U9RXyVpFxLp+qwSrwyuPp1r3HS7iQOl5BkFwGDKaQHp1FZOjaxHfKI5cJcDtnhvpWtSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUABIAJJwBXjvxN+JO1pNJ8PTY/hmukP5qh/r+VVfiz8RPNaXRtCl/cjK3Fwh+/6qp9PU14/ncw9aYi42WOXY9+tVZG5x6VYnP7vHWqROTxTAU+meKCeKT1yeKM5FIAPNKvtQDnHNKP84oAB05p4GfYfSmjpzT8/nTAUdTk0uecEggU3jP3ePSjPY9OlAF61bIHqKurnisyzb94QemOK1E5oAsRybT0PI9avW1wGwNxBzzxVBRSquDlfXrQBvWk4JbGM+hps8+HxxnvVO0WTYxPQ9zTZ5ATymcUAOnmLMQCcCmLubbgjB9TUbyBgOfyFAdQMYIz69BQBMpXqW59BUokAOMHJ7elVgw3csf8AGlLD1z+FAFxZRuGTT/NQjp09KpDIyRk4oZiv8Ix9aAFuZuSoIGeeapHOCcZ96jmkYMeQPYCoyxbG48j1oAeXCkeveq0km4nGOKkb5hz69arkEHnnFADGbPoeabuw3J605vTH51F1zxz1oAlhuGifBOVNX9+4ccisg9flGc1NBOU46r6elAF/6USDjjpUaybgMYIp5II44x1oAoXKIw54P5V6Z4Kv/M0OOOM/vI22kN715pc84wSxrpvhxfPFqTWkgGyQd/WgD0Dc8cgkd8spyCvauu8N+ITdt9mvsJN/A5P3/wD69cldzxglUUkjsP61mNK0cwaSTawIIA7UWA9mormvDGufakS3umJkA+WQjG7/AOvXS1IwooooAKKKKACiiigAooooAKKKKACiiigAooooAK8f+MXj/wCyiXQdGlxMw23M6H7g/uD39fyroPiz43Xwzpn2OxkH9rXKnZj/AJZL/ePv6V83TSNKzO7F3YlmJPJPrTAduz15qW3HzA96roRnr3qwjFcj8qYh0jfexjNVj69OakZ8k5OaZ/FxSAM5HWge5FIaXvnFADvzFKO1IDjNHtQA7PQcfnTwcDGScelMB555pxxgZ6UwEB9+frSZG456Gg8Ej3pu7B4akBYhbDg8gA9O1a0L5FYg4IAq/ZOSwA6UwNm3UuORx3NaMFuuwgLk46mqlmnA9O7A1rQwl0/hJHNAAY2W33YIz3zWW6sGXI4rWv1224AxxWOcnnnIPUCgBfLbq36nNAXJJI4JpoOEGTimByo4AGe1AFyKJW4yR9alFsu7OQfwxVWB89cfhVsMaAHFAvC9fpUEgO05x0qcM3PJpJQdhI647igDGuf9YemPYVDx7VZuHBkOVXPeq5bjjigBM02QAg5x+NKWOSeeajlbCkk//XoAqk8njP0oP8Qzj8KQtnnikY8ZAFADB0/+vTcsOgpCcHjmm7gBxxQBYhlKc44PWr8bBwGzWUAck/8A1qsJOUOFHHfFAFi8ZIxyRk96z7HUmstWtpwWARxyDzirN388W7FYN/8AKQQelAH0HaMJrWKaOTKuA3I9azbtoYroAqXkcEccgVmeC7+XUvDtrvydgKsyH0NaOpRlEDQBgwYHLc8UAaOm3IZcKSu38K7bw14gjvpWsZ2xdRjIJ/5aD/GvOrPcswLuCp7CtYym1uYZ4cowI+bvmiwHqVFZ2i6kmo2+cgTJw6/1+laNSMKKKKACiiigAooooAKKKKACiiigArF8X+ILXwzoc+o3ZB2DbHH3kc9FFbLsEUsxCqBkk9AK+X/i34vbxP4gaO2cnTbQmOEZ4c93/H+VAHM67q1zrWqXGoX0vmTzMWJPYeg9hWduPam7s0lMRKpz0qYHLdaqjIPf8Kmi5YZoAeaO1BoBOf0oAD6Glz6+tIM4+lAH+TQALwKdnNNx165pQTk5oAdwKXOO3FAH1pdm5h6d+KAGHJGOTzUscQzl/wAjxSxrtOc5we9OUFnJz19aYBJGOqH2q1YptIJPPpSwxhcktkntT4eHIIGfpQBpW8hVsA4J9K17S6KkANXPxZ3YwT+FW0dwygnFAG9LJ5ilHwT2rPeLZuyCMVZzkqwJO4VDqJwqkHJAGc0AUZX+bAyB0xUO7IphI5PekGOTjPFAFiFwGA3Yx71o53KD29axoyOec1dt5jjB7UAaMQ3ED+dSl9iAYz6moLZ8p2wPWopZB13AgUAVrvAdtoGD9KqMBjnirEhySexqqfvdKAEAB9aivlwQoyBjP1q3GMc9h1zVW6+aUnjFAFAnB9utMPpjk1K8ROeMClwsSjnJ7UAVzG3ViBj1pQqryx59TTZZGY8HAqIhscHjtQBLJKDwmMd6VWBOB1qHaenP4UAkdc0AWkYZx19Rms7UIGGSMlT6VZjk42kcirEYEvDcigDf+Et+sc15aOQrEblGeK7zVPOmtHUR7VIIJzzXnXhWH7P4gt2hCbZDsYHoQa9PvEhSJw/y9+tAHPWsv7lG3MCB9elbdwkl5pobeUxznPNYFlOBNNGiBVVsrgAkg1vaTcK8ckb7sj1NAF/Tb+bSVju4m3YX5gT972Nej6RqNvq2nQ3tm4eGUZHse4PuDxXkltKtzBJCUKhHKkkVk/DfxT/winju58N6hKRpt84aB3biOU/0bp9cUmB77RRRSGFFFFABRRRQAUUUUAFFFV9RvIdPsbi8unCQQIZHY9gBmgDzj45eLTo2iLpNnJtvb5SHIPKRdD+fT86+cCefetjxhrs/iPxBd6ncE/vm+Rf7iD7o/KsYdOtMQ4Z6inDpTAee+KeMYoAcvSpIeWHpUS57VLGTkDFAD25JyTzSd+tObrTeP/1UAAOD1NO79RTehpRnnrQAvalHWg59aVF3cDr/ACoAVAW+XA+p7VOQFAwR6GkVQq4H4nNO6gDrTAQ4zjJ/GpYFPOBz6Y5qS3tjJywwuela1lbqhICgdqAKUNvIckLj3qwlg33yw+grUSPFSDCKBjPsaAKcdtkADII61J9hcsCDwPWpdxDZHHoKs7slT2PUehoAe1q/kDpVCZJSduwkY9a2ZeIACehqomTJjgH3NAGE9vMj4KH69qjAIOO9dUIw6ckZ7VXe2Q/eVT9BQBz4JyOPyqWIMBhgwPatdLZV+6oGPQUwjyzhhkUANtuVwwyajlWR2JUMQPQGtS1KDAwPyqa57AAgHmgDn2ikaPhSDnuMcUqWQY4L/XHatbI2sCTz09arMQn/AOqgCH7IoXGWqtc2qgh0Axjmrkl0iKM55HQVSkuGf5VwFPHTFAGZd7VYgkL71SMqAHuakvldZmGSeMdaoA8jkmgCZpcEnH60gnUDhTUJPPNNBxQBbF0Om0kUjz99p/GqynnocVPEpf73AHpQA5XDnG3j3qQSoOAuD7VHKQvCYAHFRDGaANPT5xFcxybj8rBv1r2OGJbq3WU7XEi9favDY2wxK5+hr2HwreNc6LaHo4XBPsKAMm7tzBqzb1VN65AA64rS05DFfIxUtvGCSadrFsWuInEy7gSMEVWlt5ITE6NyrdaANcqVnmHygMua8X+LEUsWsQXWCpI4kXuexr2SaEvcRSGQ4xjHavP/AIvwrLokLAgPA3I9QaAPXvgx4yHi7wnGbmTOpWeIbkd24+V/xH65rv6+MPhF4ubwl4xtrmRyLGciC5HbYT978Dz+dfZqOsiK6MGVhkEdCKkY6iiigAooooAKKKKACvH/ANoPxIbXTLfQrZ8S3X72fB6Rg8D8T/KvXZpUhheWVgsaKWZj0AHU18f+N9ebxH4nv9RdiUkkIiB/hjHCj8qAMPODnpR19DTSRxmlHQ0xC9umKetNB9acMZzQBJ/OnxdecVEOvJqSPAGcUAPLUgb9aQ4yCTSBh2oAfkUmeemaQUvU8dKAFBz0zU6YPamRoew6nFWooGY5Ix+NAEajJOe3pVm3TzHHJx3pfIKrxgcdKu6bEDkkDPSmBPEuAOKsI4Dcjr6VMIQBg/SqV07QgtGMY9KANSN1AAJIH1zUM8qqSOlYwvsjlx+dVrjUi2ERzgdT/hQBpTXvIEZJYHmtS2lMkQcq1c1ZsC+cEj61vfagLUKiAcetAGl9pwm09cYqBpVDDHJ6kEVUt3DS7WycnOf6VceIKgx/OgCaG6VsBWwfQnFX1ZXjOF5rCt1BmX8a1VbC9OR6UAQ3E8UMhRjgmkSWOTGcfhUepIZYt4ByPasuIsOVb9aAOog29gvpU11bmSNWUY9TWFaXjrgMAeeuRW1a3qSLtZsGgDGu4pkddrlgOcg5NUrgMSSSePU10l1gDjkH0rNuFjkO1hj1NAGM7EkLzjtmo1OWx6+1WbmAxSAjDKT6UwLhs4PHNAFPUVzK/OD3rDkBUsCOK6G9wx3c5rGuEyp6ZFAFFiQf8aTfwRQ/60xBlhjrSAmQknjNWS4UYUnJ9ar8Rj1NIG5pgTl1PXOfWgd+TioweMZxThyOMUgJkPXrn616b8OZlbSJoySxjfOG968sU468fhXe/DWVmmuIScDAbOfSmB1+tuixBmVuCGyFoMyPaFtpYdeRU+piQ2hEZGdp461DarI9r8xAyvUUAWllRraJgpB9MVyPxDsPtnh+9mkXmIZQD+tdhYKBbYPzYPpWT4sic6dcrEN7yIR5fqMUAfMZO1zX1t+z/wCKv+Eg8GJZ3Mm6903ELZPLR/wH8uPwr5NvkMd1IrcEMRiu7+B3ic+G/HVmZX22d4fss+Txhj8p/BsfrSGfY1FFFIAooooAKKKKAPPvjhrx0bwRPDE5W5vz9nTHXb1c/lx+NfLe/J9PpXqf7QWtG/8AF8enxtmGwiCkA5HmN8x/TaK8sIGee9MQ8Hn+lKf0qNfYU4daAHjmnjpnNRqeOnFOz9KAJFOM+lOQ/lUSntT4+vrQA/3oxzQaQfT8qAHd+KnjQ4y2BTI15Bx3qwvHBoAlhTg8D8avxAEA/rVCMgNk9Pyq/EflGKYFmKMM2O1a8EUaKOAAPas6xwc+3atSMll9vagB2zcOO/tUE9srp8wq2gyB0pzJwf0zQBx+qaZ5ZLxZ9cetYzDA5ruryIMOnP0rnL2ww5dRx3FAFfTXIYKxBGK3Vb90ACMfSse1jCcjB7e9a9pGZYzt4I9aALmnxeYSwyfwq05xkE4HbinWkbQWj7SAx9azLkujncTnrQA55SpVhjcD71agvWdTnjHp2rLEoZsP+dSRZHfIoA0ri5AibknjpWWpLNn/APVRO5IHNRo3PT8KALIby/8A61PW7wRjHHc81TkJA6GoCT2zQBfe+lLkq3y+makjvyfvHBHqc1l7iOxoVvnHAoA2TOrrtcZHqDULlccA/nVRJ8Nh8BfrVgSRKCNxYHqAKAGPzGw4/GsyZCDkD/61aMxJyY/ueneqLDLHB5oAy7hMNkdvamRgLljWi8WeWAxVCdSW4+7QBXdiTkilBORmkIweOtH0pASA8cGpVIyc/wCFV14JFSCTHHagCXuK6v4eTGHWgAeWQgD1rklOceldD4Hk8vxBbYGQSQfYetMD1a7QPbESOwzxx2qhpQQWmEmkYDIyx5rRmbdG2PmPoBWdpTERyhrYoQ5GB3oAs6c2Y2Cs/BxzU14EUkSYJZcbj27VDY3GPNDKwAc/hU2oKbmFY1wFdcEnsKAPmPxLB5Gr3SA5AkYZ/GsyJirAqSCOQRXQ+NYhBrt5EoIVXIGa5zikM+3vhd4g/wCEm8D6ZqDNun8vyp/+ui8H88Z/Gurr53/ZZ1/bPqugzPw6i7hBPcfK4H4bfyr6IpAFFFFABUdzMltbSzynEcSF2PoAMmpK4z4wan/Zfw+1V1bEk6C3TB/vnB/TNAHy/r+oPq2sXt/KSXuZmlOfc5xWbnJOT0oyAaazA/WmIeCffNAIz0xTAf8AJpwGR1zmgCQGhfc0g6CnYoAD+VPXORTR7cinLnI6mgCY596dHHuOTxSqhOM9KnVeOP50ALEuCM4HtTvujgAn1oBCnH8qNxU5wCfcA0AJkKeTzU0dyVxn9Kq5IzgD8aidj0pgbmmXZkc9gPeuhtjuVf51yOjkeafwrrbPmMYoAvRgfjTyCcjofrTYx6danUHnNAFOaIsvA5qpPZbounWtpYg2M4pZoQqgLzQBxj23lPhhxUsQLthTtP1xWrqNqWRiByKoWEReYDGeaALU9xJEqow3DGM+tRzslwgAznHUdqlvIX8xT5e4D2qlPE+7HK49TQBGbZlOHf3xirMTpHCyYDDPeoCJSu7cNvqzUiIxU9OfcUAMmkUnjAx3FNXHBJNIUO4/dp6oRwP5UAMkGTTZFxzmpniOQOv1pJoiB6/jQBRL4zjJ5pPNfHDYP1pZ0weMCoiMjoKAHyHevIBYetOil2gA5x781GgwaQ9eCcUAW4btFbDfdPrU37rkjB+lZZxg5xjrRbXDRuUble3FAF2dQ4wDj2qlLARkkZFWyysPl70hYqT3X+VAGNLGQTgVG2K050GSeMGqEqMD0pAMBwfal9MdKZ+BFKOTigCRetbvhIj+3bPLbcvisJUJFbPhVW/t6zwpb5wcUwPZJMiNlU9BwDVPTklxPmQH5zjHarTcxnzGPTkVVtxEglChl5z9aACxhObj947EueDVzUcxWwdX2lRms2w4SYoJBlm+8K07sr5CCcccUAfOvxAdpvEF1IUKFjnae1cpXZfEdR/wk17tbI31xhpDOx+E2tHQfH+jXhcrEZhDKf8AYf5T+Wc/hX21X57xMVcMpII5GO1fdvgnVf7b8I6RqOctcWyO/wDvYw36g0gNuiiigArxj9pTUfK0vR9PV8ebK87AeijA/wDQjXs9fNv7RF2bnxtBbZGy1tUXH+0xLH9CKAPKMknjpSEDuakkIwQp/KoTnPrxTEL60q44yc0v86Auev8AKgCRT707PoaYBTgCTwKAJAeeKnhBLgmo4ozn3qwoAIzyaALKhQnX8qRiOAuPpTScgjioyeKYEynByOlN5JOajUnr1pDIRznj2pAEjY9ai570jNuP405Gz+HtQBqaEMzHcK7S1ZEjHHFcPpk3lyhTwCe1djbfPCMHmmBoLKNvCDPrSLM2fuqRVFg6sAxI5qzCfm5BxQBpWziQZPykdu1WNoYH1FU4htkzxitBBuG5fXt3oAqm0EikHp6is02rWsx2rwe+BXQqoKEfjis3UWKx5PAB7UAYGoeb5mWLc9i1UJ1+ck9TzWrfbXQ7uCO9Z90Cioc8EemKAKMjEvk4/DinRMemahZlz/jUlo430AL39xT42PqeKbIeT2oiPzUASmRt33jUryNtGTn1zVcnMnHpVoYYDJyKAKFyefuj+VVgUzyMZ9617qACIPjP1FZr7R2AoAjAQnOWA+lMkwcgHIqQqOuTUDNxnr+tACFDyfyqpkiQjpVlmJVm9uOaoFvnB5zQBchkLcZ6e9WRLheSCfasuSVjzu/pT45uMHv2zQBoCXI4HHpUMoDA4x9MVGj8j19qeG+bp+BNAFORCP8A69RAk+laEio4yuQaqzRbWx/SkAwE9Mnit3wcT/b9nmQqA2cmsEDBAIrp/AUaS+IYdyllAJ+lMD1d2znapOR1PQ1FvdFk3x7h/wDWp+11cLuwtRSqxWTbJgk9M4oAbaTfu/mQjcTxj3q5qWWtdqBcnAwe1UooBvChzjvzzVjU5BawrKDhVIyO9AHzz474167QM52OQS3U1yh9+tdF4xn8/Wr2UjG6QmucPtSGKtfWv7Nmp/bfhytszEvY3MkOD2U4cf8AoR/KvkkV9C/soagfN1/T2PDLFOo+hZT/ADWgD6HooopAFfJPxivDd/EXW23EhJREP+AqF/pX1tXxb40nN34u1uc8+ZezN+bmmgMMnOe1L2yetN78mgHHWgRJkjt+tPUnqeBTByeanjTPPegAUbm6VOi7cUirjoP0p469KAJFx9KFODkfrTc8ngUBjn0oAlVtpz39KRlx9TTRzgk05m+Xk/jQAmfwqJmzSOSc46U3mgBfwFKDim80qgkjGKAJ4nywOcHtXYaBe+ZGA33hxiuMC4PzcH0q5Y3TW8ysOFzg0AegTbXwV6+gqOJiHxgjnsKp2k3mopBJrYtIw5yVxjvTAmhPyhhz/hTp7gqAMnA7AYpZ2WJtqnJ747Vn3UgxnPP5ZoA1rS9DLhyPrVHWZP3TFSPrmqUUqg7WP0pt7NugkUnPHFAFEyZAyfyqnqcwIwp4A65oeX9ytULpxsxnJzzQBU3Fj2x61IJShAQ9Kqbjzg0qg8CkBrCUOvXpT4m9Kz42wOufep0ds/zpgXY+ZMVMh3Hb0qtA2WyByR6VZhOJQeQfXFAFmdg0DKAcisebIJ4596vu+JDzkdCKoXKncQD70AM3Bkx0NVZD8429e5qZBx1HvTZIuSVbmgCCYARNgjNUWPTHSrt0HEWT371TK+/Pp60AJmmZ57UvbFNPSkBPE2R1/CpwfXqO1UUYggirCtn2NAE+45BP5ilDBvvYqDexPJH4U4EAf/WoAWSIZ4ORXV/DmF21aV1OCkZNcsPvdRXe/DeLatxPs5JCBqYHbROnm/dbIHX0qCQRvLgqcjnINWMMH5wpx2qEkr5zso2g4BFAFeGRlnJwxwMDHrVrUGRo8vjCqWIPsKgsJQ8gCgHOWJ/Sqni2RlsJ5EO0pGSxX0oA+efEUnmaldODkNIxz681kGrWoSF7iRs8Ek1TJP4Uhig169+zJdm3+Irw5wLmzkjx6kFW/wDZTXkAr0L4D3BtvinoTA4DvJGffdGw/rQB9mUUUUgCvhrVpvN1K6kyDvlZs/UmvuWvhCZiXJyTk55poBC3AOfrSjtj8z2pigtjAqeMZHTPrQIfGvTHTpViMYFMTjt9KeCccigB2cU4Z6Gm7sdf5UZOaAH5xScDimjrSEnOc0ASofWkZvSoi/b86UHvQA5ulNHWjnnHNKME4xj3oAXb781LEhLLjAGaaARzx+FSIx4wR9fSgC7cJG0OQBkdMCqSjnpVtS0ibQccd+KrDKvzzigDp9CuPlVSfmHFdEbjCgA/jXA2szRyIy9c9K6eKV2KsfukenSmBozT9ieTVC5uiCRtGOmaUE7iD830qC82lOoLegoAdDOCwxS6g+22LA89OtUrfd/COamvN7QorDG40AUp3xCpH4cVRfJY5HHr61oSAKoDZ6VCE3EnjNAFPys5IyPcClVNuTirxTb1/lUZXjHp7UAVs7RxzipoTg8jjFIVBPQkfSpEQKB60ATRkgk44qdG2n0qBcYHQUKQcd6AJpyN+RjFV7ldyBgORU7gYyRUWRtY4/KgCoTgHIxzzikDfMMH9KHbtgAk1GGXnnBPrQBHeEsBxwKpjP0q7MMxt7VT7dOtAEZY5OelMzycU5vpTDzSAWnq2DkflUY6+lO7dfxoAnDBhx+VIp54qJWI5FOyM5GaAJ0PTnivVfAlsIdBTzD/AK1i2K8rtlM0qIudzEKAO9e1aVa/ZbWBIwNqRgEHjmmBaXAnYKegA5pl4hWEIpGWYkgmnWB82WaQngNjpWfrc+wFomUSEbVU9zQBLpVvunln34XO1cHjArA+IF8LfQbyPP72Qbc+1dHp2LeyVCrK+PwJrz74uXQjtLeAY8123sM5IXtQB45d/fNVzUlw+XOKhByetIY8da7D4SyeV8SPDjet9Ev5tj+tccODXU/DQlfiD4Zx/wBBK2/9GrQB9z0UUUgCvg64QpO6jHysQa+8a+Hdcg8nXNQhIx5dxIv5MaYFFCe1Txkj6VEoHSng89fyoETBsHil3+pFQggZ6fSlzwcZoAlDGnbiKiyBxg0A89Dn1oAkDenWms/pUbtjGKTPc5oAeWODTlcgDrUQPPBFOGMD096AJ93BpUOB1qJDg1LxjIxjuKAJFbnGaeHAX3qvnHegyfnQBYS4MbZB5pktyWkJzjNVs5pD3oAv2kx8xTjvXYaU/n2u1TkqeK4SBC7BUIz9a7rwnaOm5nbOcUwJTDKCeo/Cobi2bIYdfpXYrZRSYJwCaZNZQKPWgDA0+wY7ScrTtUWONkQEZUVvKi4AA2j27CuR12Yfb3UHjoOaAKdxIpbgnPpUkSqDk8/WqhG70zV0KEj9TjoRQAyV1A4A5qBmHJxSynI/XiqxPJGTkUASHb3PSgkEdenpUIOD2zUgOTgjFAEm4HpT0xnpmowgPel3hTgfyoAvxoHQ4xnsKguY/Lj+Yjkc1GlzsOAeO9VbudpCQTkUAV5nAGM/nUJxk880rL8vHPvimEA8flSAeCAOeciqjEhjzUrZH1qGVcjcMmgCMn8xTSQT6UHkdaYRyetAD+MnmlyPWmYANIep9aAJCwA9qaj4Oc80zr0zQOTQB1Pge0+2a1Ef4YQZDn1HSvWYJt8DOCS3PGMVxnw8sjZ6Y1xIh8y4OV/3RXasoaFf4WbjNMCW1Bt7EZwWbJY46k1hQ3C6hqWV2skfrWjr87W1kI0Yh3+UEDoKqabZeXEoZl3v8xI4NAGjdki3KlcMBxz3rwr4m6i1xrUqbwTGAnFewazfpp9lPPPIP3akjPPPavnLV7t7u7klkbczksTihgZ7HJpooPWikMeuM811nwwUv8Q/DQH/AEEbc/lIprk1ruPg5D53xM8OoBnF0r/985b+lAH2zRRRSAK+MviNb/ZPHWvwgYAvZWH0LEj+dfZtfJ/x2tBafErUiAds6xzD8UAP6g0Aefg+pP8AKgN2/Wmn7x9e9ITxTESBsg+lG8//AF6j3HPuKB6459qBk6nJOeOaVmAz2NQl9o/+vTA+7qevSgRJv9ePoadk/wD16YCCc0oPpQA9TzTwSBzUYOPXBpTQBISMU5HIPB47iolOetO6HGKALJIboKikBHXofambiMcfnT1bPB49aAEXn0zT0DMQoHJPApuOtb+i6YF23F6SoIyiD7ze/sPegCXSNNJeNI0Mkh7Dmu70vThGq+dKi9tqfMfx7Vl6eSwAUCOPsif1Pf8AGuisVAQYHJpgaESwInAkPvwKdDDbTSbZGmTPqw5pUX5OaDH/AHhQBHcWixSFYZVcY6Mea831wSR6rKrAg56GvR73ZbQPJOdqquSB1NeW6rqhvb15Smz+FV64HagAtlLyjOQKvXRwQPbmq+l/MxJOQBTrh+WbtmgCvIy9MnNQbxnBPT2pkrd8Y7VBvz6/WgC0HHYKPcVIJFUEmqqsFGMrzS7+OT160AWTNgdqrNdNu7HB9Ka78NgfhVIuSxoAv+fub7uB9KGkGQTxjvVLfjqQPxoLjgbjzQBYLKejA0hHGBzUKvnufringcDJIHvSARuBzQR8pyMU5niVRl9x9hUE024YUYWgCu/X2ppJ57ih/vdKZ1yaAH5zTWPoTg0Hp3FIfxoABnriruk2j32owWydZHA+gqmBjivQPh1o7mGW/cDLDZFnP4mgDt7exhSGCBM4iUAHNaW4BhvTj1qraxbSIyxJHfHU1JJJLvbGCg+Vfr3NMDNvwLrUVfcyrDzwO9WILkJEzy447+tQsI2k8uPgscnNNvjgIq7dqnLH+lAHDfFbVVt9MW1Q/vbk72H+yPWvGpDk59a6Tx1q76nrc7Fi0aMUX6VzBPNIYUCkpRQA9a9O/Z5tftHxT0pjyIEmlP8A37YD9SK8yWvbv2WLLzvGmo3Z+7b2RUf7zOuP0BoA+oqKKKQBXzn+07YeV4h0m/VcCe2aIn1KNn+T19GV5J+0ppv2rwVbXyj5rO6Gf91wQf120AfMe7mlZuMDGfemE0gY5xTAdnn2pC4A4IqJ3+bg8juaYznOe/1oAmBJOelPBORjHNQIzd+/WpFbPuKAJgeO1SIeT0qNOmQalXGOuaBBnn6UuRkZ5pMmkH16UASBuOnNKxqMEY7U7PHUUAOBx1oHUY5OaacZ9fxrRgUWcazSAGdhmND/AA+jH+lAFuyjW02tOoa5PKIRkIPU+/tW5aqZGDOdzE5JPNc5akvJufJJOSa6SzONvX86YG/ZLhRW3anHIwPesG3lAAz0+taNvdAfePH1oA3om4GevvUz3ARQEwp9R1rJhuAAOcY4xUN5ehVPIzQBT8TXypZyZPJHevOSCWGBk57Vr+ItUE7eUjZwcnFY9vITJ14PWgDZswsFkWb5Sf0qCWYGJgCvBwKnOfsvGazokkZnUkcjuaAITKCTnJ+lM8wZ5OPrSPHszlhx6c5qvLjPVufakBb8wHjcKCVJ4HNVoyvTGT71NnHQcUASMV2nBFU2BJPNXYQGPSpYoE81lZQfw70AZbsUGf6U3zWweg/CtSa1UrjafzrOMQHTjFADRI5H3jQSc5JzS7OD8wPNJsJHUUAL9DSM2DS7GXkjApp6GgBGIx7e1Rk/n70MccUwk5weRQA8nBFHfGKaMD6U5Rz9aAL+kWMmo38NtEpLOcHHYdzXtGmW4s4I4YIwscY2qMfma5bwBpCWNot9cBjPMPlXH3Vrs5ZF8sYIV2+VM9zTAesgETtIrDrTNpt7QsvJIzj61OiEIiSnIHGQOtVtQlVWB3YRfmPpQBRffbwvKR855x2z2Fct401ZtL8PzM0oN1cD5Mfwg10n2xLiTY4yP4cenua8Z+JGtrqerGKAjyLceWuOhx1NAHHTOXdmJySaiNONGOAaQxBThxzwSfam/SnjnFAD164r6Y/ZT0/y9F1zUSmDNPHAD/uKSf8A0MV80IOa+zfgNpf9l/DDSQww91vum/4Exx/46FoA9BooopAFc/8AEDSv7b8F6xp4G55bZigx/GvzL+oFdBRQB8Cy/LkHioGYke1dZ8UNGPh/xzq9jtKxCcyRZH8D/Mv6HH4VyP17etMAzmkOTz3+lLkAf4UHBPb6UAKv1qaMdcnNMUA88DvU8a++DQA8Ln09OlO7Ad6aT2/Ck7Ek/TmgRJkc8dOKTcPXr2pF4FIW7CgB4YbeaD14zTN3AFTWwEkgDttQdTjOBQBbso0jX7TMuY14RT/G3+A71FLK88peQ7ixovbkSsqoNsSDCqD0FMhIzQBp2jBcE1r29x0FYCyAVYiuMY5/pQB1EE/IwauRXm3oa5eO92g4PP1ps+qiKMs5AAHPNMDsH1IKuWbAA65rl9Y8QmUtHbnPq3auXvdclu2KKT5fp6+9Vo592MsOOlIDUEhY9SSa1rG3+QM7BSfU1i6fIpuEDc8966aKFREPm5HPFAFp9rwqA2eOxrPSMi49s1Hct5eQT/8AXqpHKwYkcEHrTAnvAN55wfwqntHGXHNUr25bdkED86jguMsOlIDVVEBwX/IVKgjx/rCfwqorZAOQaepHFAGtaRx8/vBx/s1ZgRGcneCT3qjaHCkbqs2rc496YE00ZUjnisi7gKSH5eCe1b7AufWqdyjAg7cgigDEYdcCm9jVuR1/iTPb6VAxj7Kc/WkAiD24psqAg4xupxcH2PpTc8c0AUZcg+hpjdasXDZkOKrk/MetADx06V0/grQzqV8JpsLawEFif4j6CsjRdNn1W+jtrZcs3JJ6KPWvZNL0yDTNPigt0UhP4h/Ee5pgaEaKdqRABVGOKbDGt1eAyRcQ/dY/zpIYQVMcW6NjySKvqPJhCtksepoAZIwTLHAQDjPp3rBunjv5WTHy5yf9qpNfnd4vs9vIQW+8e9ZdvJ5FtLJPcELDydvJb2oAzPGV22iaCUiZUuJXIG084xXiF3uaV2b7xOa6/wAZa2dX1SSVSREBhASeBXHTNvJNICAnmig0nWgYop69aZUi0AXtKs5NQ1G1s7cZluJViQe7EAfzr750uzj07TbSyhAEVtEkK/RQAP5V8k/s86GdX+I1nM6EwaejXTntkcL/AOPEH8K+wKQBRRRQAUUUUAfPv7UGgYm0vXYU4cG1mIHcZZCf/Hh+FfPz+vSvt74j+Hx4m8G6lpuAZnjLw+0i8r+ox+NfEtxG0cjIwKupwQR0NMCAnmnrzjHNRninoRtyOtAEy84GTU6g8ZOPWq6YDdMj2qRpFQdePSgCfORjOKYWH5VAkyuduWHuadcSbFGMZoAlz2FN3H+HGR61SeZj1pm8g9ecUAaQ5AxyanLGKPCn5yOaoWrH7+flWpDL5jFjQIlDc96kRseox+tVgSeMmlLBAOoHegZO8+CAOD3oFwefmxWTNc/vBjgD0qNrn3oA3FvsZ+bNY97fSXTbSTs7Ad6pySlzzUsJG3dxkdqAJI1IHzHBqdGAYckj6VT3kEluTTxIfU/hQBq20jCRSASOtdfYXImgCk/MPWuGjnO0DPH61q6ffMrgLnB4IJoEbmot8wGeMcc9aob9oOSBUl1KPLyQayri7A4C/MfWgBLpgT1OfrVaKUVFKxYEjOR3pkZwTz1oGa9tPkc9u9W0cZ4PP0rJgx0GM9qvQHgZIoEbdtL8gweevSrFnJmUAE4JzWXC+Opx2zWhp3zOWPAoA2Q5HGeDTHO9MEZpkz4TIGT6UwOPLx0NMDKuoiHY4OM1VOB2IrRmPzEnBqCQJwME5pAUu44oI5GKmZe4z1pjjCbjj2oAoMCW/mams7Wa7uY4IELyyHao9adFE0sqpGpd2OAo5zXpfhjw6ujWRvLkML1xwP7g9KALnh7QI9H05UdVN5JzK3oO4FbFhBvkxbSFVXsewqHTra5B/wBb5iO247uqj0FdDDEsMeVADY57UwFRFRRu4Ycn61mahdvhwPuAfeqLVNQLuYUBUn+L196pzXMKRrCSpU+/SgChaXLTTMyIzSZxgdh2rmPiN4jMEX9m2jorMuZtvJHtmtfxTqlroemTT+Y5nmGyNAcdR1rxC8unuJneQncxyaAFlmZicmqjH8qN3PvSHk0hiHnikxS/jSUAKKkQUxRzWlomnT6tqtnYWilp7mVYkGO5OKAPpn9mHw+bDwpd6xMmJtQl2oSOfLTj9WLflXtFZ/h/S4dE0Sx021GIbWFYl98Dr+PWtCkAUUUUAFFFFABXyP8AHnwv/wAI/wCN554I9tnqObmPA4DE/OPz5/GvriuA+NfhT/hKPBc4gj3X9lm4gwOWwPmX8R+oFAHx0QP1pFPp/OpJV2k59arSy7VwvX1pgSSzYGBx61AXznmoGYnvTWNAEhcg8HpUolLjnr61TyacGxigCzk/lSDlsioCTT4T84z25oAvuDFCqk4zzzTEYnAzVSSZpHyTUzPhRtOfoaALqDqc026by4uoyap/aGB+8aiuLhnUAnNAEDNkk03NFJQAoqVDgYPNRZFKD70ASZyKN2OlMzg07NAEiSkHnmrlvOFcEfzrNFTQ53gY/CgDsFcyWYJHNY94jbtwBwTWlbZGmocZNJaQvPISRxQIoxwPsYEY/GqyxOr4I4NbssBjBGKhWMgkg9qAKUKvjlT9auRKQMkYp5UjGB7c05VI6d6AJEPPWtXTyc896ylV+2ea07dGUoScACgDTm/1as3pUUbBw69KmA3QcjNMh/iwpHfmmBSmVg2eaiI4zyfwq3MrO2QPeqxUgcn8qAIsHJ64pLhGkkSKMFieAoHU1bsbSa9uVhto2kkY9B2/wrvtN8PQ6LEl1OFa94wSNwT6UgKHhvw4dItTfXiYuzjaCAdg+ldDpcd9d3btPte2B3K/c+1S6fa3l07m/wBpjJypHce9b4EVtEEjX5R6CmAgRYI8qvzduO9Zt/eqqtgke3ep3nEh37vk7VRuIkmJmm4K8r/jQBEQqxNJPlpGHA/pWDeeXp1vdX96ybEGRvPBbsP/AK1TTyysk9xdM620A4IHWvI/G/iaTWbnyowUtIj8q5yWPqaAM/xNrlxrWoPNM2UHEajgKPasMnPWgkmgj1FIYlGaQ0DrzQAtOHGM9KaBTu9ACqOa9z/Zj8Lfb/ENxr9zHm3sF2QkjgysOv4Ln8xXitlbS3dzDBboXmlcIiDqzE4A/OvuP4c+GY/CXhCw0tAPORN87D+KQ8sf6fhQB01FFFIAooooAKKKKACiiigD5F+PPg4+GfFb3FrGV03UCZoSBwrfxJ+BOfoa8pkHOa+5viV4Th8Y+FbnTnCrcgeZbSEfckA4/A9D9a+JdTsZ7C9ntLuNop4XMbowwVYHBFMDPNRmpWFRn6UANpKWkNADl6VKqfISO/FQgnAFS+Z8oXAwOaAFERP1p7DauD1qPzmHAOKTcT360ANJ9ajY09zURoABQaKKADFGaU9BSDigBQacG9aZS4oAevJ4qxAuHU9arLwavafzOoIyKAOmiU/2fEhX5iOla+mW6pDgA5xzzWfC++Nd2OO1a0coW1BC4zxwaBFO9lAYqACBVMYP/wBaicsck81Ar5cgkY9qALLRqxJ6GhVHXim5J69MetSKeMZ/OgCSMEkY/U1pwR5Occ5qlbISQenvV+OQKvA5B+lMDQgwwKZxQ0ewHjOeKjtpAMMCc/WnXM3Zdx9h1oApSOYy2ce2au6Jo13rcxW3UiJTl5G6LWvoXhGa9xd6kxt7cnhCPmb/AArtLXT3SPybIm2thgDjg/hQBn2GlR6QsUNgM3DcNIFzk1sWlu0cYfUCjy54A6Cp45YrVRGh3y4wRnn8TTWUn99dkADlQOg/D1oAmkcqn3eD6VXWTzXKocqv3z6n0qVQ8i+in9B61BcA2samFfkHWgBt3EGTdGVBX8q52/vnZDLJIsNtGcO5B5PtV+5vwwfJ8q2H3nY4B9hXl3j3xU1+ostPbZYpkEjgyH/CgCj448WHUj9jsndbKM89vMPqfauEkOWPpUsrAng/rVc9aQxBTqaOtL2oAQ0g70p5oAoAUCnrnNIo5rZ8L6Hd+Idcs9L09C9xcOEHHCjux9gOaAPWv2avBn9pa0/iK9izaWB2wbhw82Ov/AR+pFfT9ZHhPQbXw14fs9KsFxDboF3YwXbux9yea16QBRRRQAUUUUAFFFFABRRRQAV8/wD7R3gHzFPinS4vmAC3yKPwEn9D+FfQFR3EEVzbyQXEayQyKUdGGQwPUGgD89JVqFhXpnxk8Ay+DNfY26u2k3RL20h52+qE+o/lXmzjmmBCaQ09hTCOKAE6CloNFACkEMQeD3FGe9IOTQx7CgBGptKaQGgApKcRxSUALjjNJjNHalFACUUGigBR2rR04hXyeB61nr1rQswScYzmgDpLFwyDPeteUhYI4+x5NZGlRszdCR6YrRVPNk+VTgce1AivKuD0BFVGiAbI7+9aMyELjHbtVfaTk5A+tAESjOQc4qzGOB6U1V5GMfjU4zjGRj2oAlTgUrMV55wTTreGe4kEdvG8kh6KgyTXW6N4Q3Txf2y0kS/e8pUPP1PamBh6NZ3Woy+XbqCO7k4UfU16Novhm0sNjv8A6Vd/3/4QfatS10+2jt/ItreOOEfwgfzNXlSK2QEEf59BQBWhsfJPmzMzY52k5H5VJNcmRAsJ2jtgcmmXMwbBBIz/AA9zRaxEFjONvdRnJoAbBDskDOgBbsPX1NXFjzuMhBHYelP8vco4x3AP+NVrm9SDPmHDjvj9BQAy5nFsSHGVP5Csm6v4TbSS3Mgjtk5LN/FTtR1S0s4TdX8irGOkfVnNeR+KNfn1e7kcjy4c/LGDxjtmgC54w8TPq0/k2o8qzj+VABgt7muGvwSvOcVffByODVO65jYGkBiSH5ulMPvT5Pv1HQMKKO9LQAUqjmgCngZxxQA5FyeOtfVn7PfgH/hH9H/tzU4sanep+7VhzFEeR+J6/TFeZ/AP4dnxJqq6xqsJ/sizcFQw4nkHRfcDv+VfVwAAAAwB2oAKKKKQBRRRQAUUUUAFFFFABRRRQAUUUUAYvjDw5Y+KtBudL1JMxSjKuB80bdmHuK+K/HHhW+8J69caZqKfOhykgHyyJ2Ye1fd1cd8TfA1l440NrabbFfRZa2uMco3of9k9xQB8OsMGmYra8S6FfeH9WuNO1SBobmE4ZT39x6g+tZBGKYEZ2n0FNx6U8jg00/SgBKAOaU8U00AJRTgM0YoAbik70/GBTT1oAMUpGOtIaM55oAO9GKKVRQA5BVu2kdBhWx61AgzV20iLIcqDnjmgDp9EncW24gZI61cFxjbnsfpTNKixanaOAMUydBu2Y5zk0CI5Xd2yc4HQZzULSNkjb+tXbewuLqTbbxSSN6IpOK6vQPAk99Juv7hII1PzIBlvpQBxdtHJK4SNGdieABk122heBL66RZb1haxnnaeWP+Fd1ZeGdP02JfsUbI6nmQty341sRHeRklyOp7UwMzQNKttLgMcNpEkvQyLyT+JrXe23fNKeB1GajurqCzXMhz6Ad/pWTNrDTv5cZ2qTjaDljQBfmv4rY+XCwJxwAaoT3E9y5WBSrHv1x/hVeHTZppA0oMEfXIPzH8e1dHaWIjiCoAE7k96AKunWxjRS+Hl7kdauyRLGfMY/MO3YVBc3MOnKxUMzdcDkmsq51NJYmlvXa1tl+Y7hg4oAuT6xEWMcTfMDgnHFc94g8UafpCPHvF1fMOEUcJ9a5Xxf42W7jFrpCmKEHmRuC34VwjSO7s8hLOTknrmgDV1XVJ9QlLTuSOy54FZUn0FONMb1FICMg856HvVC8bPAq82D3ANZ055Jx3oAzZh8xNQmp5/vc9agNAwpRQBT1XNACoK7X4YeBrvxtr8drFuisoyGuZ8cIvoPc9qzvBHhTUPFuuQ6dpsZLMcySkfLGvdjX2b4J8Laf4Q0KHTNNThRmWU/elfux/zxQBpaLpdpoul2+n6dEIbW3QIij+Z96u0UUgCiiigAooooAKKKKACiiigAooooAKKKKACiiigDhPip8PLLxzpf8MGqwqfs9xj/AMdb1X+VfH3iPQr/AEDVbjTtUt2guoThlbv6EHuD619+VxvxJ8AaZ440zyroCC/iB+z3Sj5kPofVfagD4eYUwium8ZeFNU8KarJYavbmOQHKOOUkX+8p7iuedDmmBBSqASdxIGOwzTsUmKAGd6KUg0DHFAAfbNNxjrTzik/AUANxQBxTsU4L1oAYBTlHFPVMmtPSdD1DVZAmnWU9y3/TNCQPqelAGfGDnIFbelwsU6EZPpXe+HPhDeTujaxdLajr5cXzt9Cegr0zTPAmi6ZCEgtTJJjBkkfLfWgR5x4S8M6hex7hAyxN/HJxmunh8Ew21wss+245+ZSSB+ldvDBFZJ5a7ggHQZOPxqu84O8RgFiei8mmA63htLGELbQw26+wAprSokpKJuP97tVQRyuGlmcKi+/T8ajvL+P7NtsVNzJ12qOKANMyjB85twHvgCsPUdc27ooG3HPAA4x7UWen399OJrlmiXoU6Ctu20G3V0kVP3ndu5/GgDnoLO71JCZN0JPqMsfwrd0bRkgQbo8v/fbk/nWti2tEJJXIqndXlxcExWSlDjhyM0AW53gs4t07DAHesm61G7lXMEWy3AyXOBx/Ss67uE00k6vOHYjOBkn8q5XX/Fl7qML21mqWtp90AfeI9zQBtar4p0/R0Mir9pvn/h35C/U15jrusXeq3Ek1xIcMchAeBUM6tkkkE98mqpjbJ4J+nNICm6n1p8ecEdalZcn5lKn3pAhHrQAYzxzxTWpx6UwnHXGKAIpOhrNn3Zwcn61qOMjrj2rLmOSe1AyhP973qDFTyglzTQlADVXmuj8F+FNS8WaxFp+lwlnbl5D92Ne5Y1e+HvgXVPGmqLbafGUt1I865cfJGP6n2r6+8EeEdM8HaQljpUXPBlmYfPK3qT/SgCH4f+DNO8F6KllYKHnYAz3BHzSt/h6CuooopAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAYfi7wvpfizSnsNZtxLGeUkHDxt6qexr5O+Jnwx1bwXctK6m70pziO7jXgegcfwn9PSvs2orq3hu7eS3uokmgkUq8bqGVh6EGgD89WTB6VGVr6N+JvwMI87UfBg3DlnsGPP/bMnr/un8D2r5/vrKezuZILqGSGeNirxyKQyn0INMChto28ZqYpSpGWwF5J7UAQBaXbXUaP4I1/VQGtdNmCf35BsB+meteheHvhLBCI59euGkPeCE4A+poA8ahtpJmCRIzuegUZNdt4e+GeuaqUaeJbKI4JafhgPXb1/OvfdD0LTNKjCafZwwqAPmCjcfx61ekljSXcwB3HFAjhvD/wp0PTo1kvQ+oTjn958qA/7o/rXd2NnbWdusVtDFBGo5SNAoH4Cp5W2wntx0HU1labJPPcTI0LhAflYimBoM6qquowB3birJ/eRBk+b2qM2CtguS2D0q1GFXAGPpSAy72EsoLM2zoVTvVWNWjcx2VocH+NztFbN0dqjapY+gFUXNxINzlYBnoPmagDLbRzLKXv7p3Rv+WSfKv8Aia1bSzgt0228KRIO5FK0kMRGSC3qxyfyrH1TVZbZzvRliP8AGRwKYGvNcW1qhdyG9z0FUl1gXYK2rBjnb6c1mXWraZptq0uqXSuzDIiU5Y59q8/vfGcpvXOkQ/Z4icAtyQP8aAPStaa0srcS390ElABEe8ZP4Vyt742JgMWmoYc5Bl6n8BXFy3c91I0txJJLI3OWOamgjzyUGD70AaHmNeP5ks7yOe8hJNJcWJQEgA4wSRU9rGgiJORx2FLM/GVOOcdaAMO8sxtLqMZ9qzDE4J+X8q6SfPlnuc9xWJcTyK7KdoHTgUAVdoIwVJ/CnPZsYyyDn0PFSCaQjGe/an7mxluaQGUYmDlSuD6GopFwD9K15YxJHnGKz3GThh+NAFCc4QnjNZrHr0xWteoQhwBg96q6dpl7ql6lpp1tJcXMhwsca5JoAySu5jgV6h8LfhJqPiySO91EPZaODkyEYab2QenvXpHwz+CVvp5i1HxYEuboYZLMHKIf9o/xH26V7eiLGipGqqijAVRgAUhlDQNF0/QNMh0/SbZLe2jGAqjkn1J7n3rRoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArkfHXw+0LxlAf7St/LvAuEu4flkX6/wB4exrrqKAPlbXvghqmjzSzS3SXGnISfOhQlgvuvY/mPep/DOm6Zo5hks7VGmLDdLON7kew7V9RVzGr+CtJv5XnhhW0unOWkiUAMfcf/qp3A5ezuBJAsgQrnHFRar5kcIkhTLDkcZrZi8P3emhlYCWL++mTx9O1JPEjRFXBbjOBQIydGne7t/MYENjkHtS3WnefhndhhgetWbBPKkYfKinoq1auVIIKjk0wHQonlrjBIHemMzBvkXp3NOtVYMScAHtUrIqsSB70gGLukGdxx6Y6UoQK24k5pyb2A2cA+1U9S1Ox01N9/dRxgfw9SfwFAFqdiIiY13N2FZt3bzzW53SLb8dc9PxrndU8eRBSml2xf0kl4H5Viwalealue7nZ+c4PAH0FMDTuvEFrpe9pIjdzD7uw8Eep9K43X/Feq6u3lgiC37Rov9am1HapPIGOo6msxgu4AYx64oAyjC7OWkyzk5OTk0CzwdxIAzWjtAkJ7GpGjDY6fhQBXiKBfnHNWYRvOTxzUYTLfw9ehq5FFtXjHrQBPG2ImwueM81QmcMw5PFXhlYmweOuKziu8jnFAEzMCuetY90v7wkrkE49a2AN0TY7e1VnjBUgjj1oAzQh7DAPNK3OAvp3q2LfqSuBSeQzsNilnY4CqM5oAz5TiIj8qqKhZsAEk9hXpPhz4W67reyS5jGn2h5Lzj5iPZev54r2Hwl8PNC8N7JYoPtV6P8Al4nAYg/7I6CkB4t4P+E+seIRHNqAOnaeed0i/vHH+yv9TXvPhHwfo3hO08nSLVUcj55m+aR/qf6V0NFIYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVUu9Pt7oHzEwx/iXg1booA5OfwxJG++3n81RyEf5T/hUFzbXEMZM8TIR7cfnXZ0detO4HnlzeWum24n1K6htU9ZXA/nXJan8T9GhZ4tNSW+lXgMBtT8+pr0jxL4C8N+JHMmq6ZG85/5axs0b/iVIz+Oa4e5+BmkxktpepXUJznE6rIPpkbaAOD1DxprerMYxOtpAx/1cIwSPdutZ80ZMXLsxbuxzXcv8I9WtGBgmtrlQf4XKk/gRj9aLjwLqkUJ32k2fRRv/lTEcDFjJxnjj61u2DCCzkmb6Cr6+DrtHXckkYzzuQirGp6FKI1ii3bVGKAOOun37mYkk/hVaHByB3PSuhm0C5APymqv9g3MZK7ck0AZRVc+pqRCcj6dquDRrpTyjE9etPGl3Wf9XgfzoAoRlWbOcetallb/AGwmKJ0Wf+BWABcnA2g9j9eOtPh8PalMwENnPJ6bIyf6V0eleB9amk3vp7oDjBfCbfwJHHtQBzsWlXV29zFDHNFPFGZURl5YYBwcjuDnP+OazoLG8nDGG2DrgqFYncTjg7Rzyeh6H88e82Hhm9mtEXU5o1lOGfySQWYAryR7fXvjtjTt/DFil1DdSgvdRsX3qSASc8Yz05H/AHyPSlcDwAaFq1qGS8tCHwHdRgnBBP3RzjjnPSp9O8J6tqsijTrKeSPj5yuxAcc/MeP1r6PW1gBB8pCRzkjNT0XGeQaJ8InLCTWb1UXvFbjJP1Yj+hr0TQvC2jaGo+wWUayD/lq43OfxP9K26KQBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUb28L/fijb6qDUlFAFY2Fmetpbn6xj/Cm/2bY7i32K23Hv5S/wCFW6KAK62NopytrAPpGKlWGNfuxoPoop9FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic retrograde cholangiogram showing common bile duct stones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mulholland, MW, Maier, RV, et al. Greenfield's Surgery: Scientific Principles And Practice, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33696=[""].join("\n");
var outline_f32_58_33696=null;
var title_f32_58_33697="Dissection of the ascending aorta on TEE";
var content_f32_58_33697=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1048px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/56901/teeaaodi_conv.mp4?title=Dissection+of+the+ascending+aorta+on+TEE\" style=\"width:383px;height:276px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Dissection of the ascending aorta on transesophageal echocardiography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 250px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transesophageal echocardiogram shows a large dissection involving the ascending aorta (Ao) and the aortic valves. The false lumen (FL) impinges upon the aortic valve leaflets and impairs their function. Spontaneous echo contrast can be seen within the false lumen, a result of turbulent blood flow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33697=[""].join("\n");
var outline_f32_58_33697=null;
var title_f32_58_33698="Brain MRI CNS met melanoma";
var content_f32_58_33698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CNS metastasis from melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 437px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial images of a brain magnetic resonance imaging (MRI) study demonstrating an intracerebral metastasis in a patient with melanoma. Following the injection of contrast (right panel) the lesion enhances with a ring-like pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Donohoe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33698=[""].join("\n");
var outline_f32_58_33698=null;
var title_f32_58_33699="Minoxidil (topical): Patient drug information";
var content_f32_58_33699=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Minoxidil (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/47/27379?source=see_link\">",
"     see \"Minoxidil (topical): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8774870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rogaine&reg; Extra Strength for Men [OTC];",
"     </li>",
"     <li>",
"      Rogaine&reg; for Men [OTC];",
"     </li>",
"     <li>",
"      Rogaine&reg; for Women [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8774871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Gain&reg;;",
"     </li>",
"     <li>",
"      Rogaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691866",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hair loss. It may take 4 months to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702534",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to minoxidil or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024327\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect foam and solution from heat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12254 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-197.136.42.3-49792BEA53-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33699=[""].join("\n");
var outline_f32_58_33699=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8774870\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8774871\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024325\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024324\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024329\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024330\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024332\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024327\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024328\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024333\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024334\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?11/38/11877?source=related_link\">",
"      Minoxidil (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/26/24996?source=related_link\">",
"      Minoxidil (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/55/21364?source=related_link\">",
"      Minoxidil (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?26/47/27379?source=related_link\">",
"      Minoxidil (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_58_33700="Bullous pemphigoid direct immunofluorescence 400X";
var content_f32_58_33700=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Linear IgG basement membrane zone antibody staining in bullous pemphigoid by direct immunofluorescence microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Direct immunofluorescence microscopy of perilesional skin from a patient with bullous pemphigoid reveals characteristic linear IgG basement membrane zone staining.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kristin M Leiferman, MD, Immunodermatology Laboratory, Department of Dermatology, University of Utah, Salt Lake City, Utah.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33700=[""].join("\n");
var outline_f32_58_33700=null;
var title_f32_58_33701="ECG anomalous left coronary a";
var content_f32_58_33701=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    An electrocardiogram obtained from a patient with anomalous left main coronary artery arising from the pulmonary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a pattern of anterolateral infarction with deep wide Q waves in the anterior (I, aVL) and lateral (V5, V6) leads. There are T wave inversions in these leads as well.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Geggel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33701=[""].join("\n");
var outline_f32_58_33701=null;
var title_f32_58_33702="Granulomatous gastritis";
var content_f32_58_33702=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Granulomatous gastritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     Beverly A Dickson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33702/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/58/33702/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A granuloma is an organized aggregation of combined histiocytic, lymphocytic, and plasma infiltrate (granulomatous inflammation). When this organized collection of cells is identified in the stomach, it is referred to as granulomatous gastritis.",
"   </p>",
"   <p>",
"    This topic review will discuss the epidemiology, etiology, histopathology, and diagnosis of granulomatous gastritis. The classification of gastritis and causes of acute and chronic gastritis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/30/31205?source=see_link\">",
"     \"Classification and diagnosis of gastritis and gastropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/22/30055?source=see_link\">",
"     \"Acute and chronic gastritis due to Helicobacter pylori\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granulomatous gastritis is rare, with an incidence of 0.08 to 0.35 percent of gastritis cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In the largest reported series, only 56 cases were diagnosed after review of 15,947",
"    <span class=\"nowrap\">",
"     biopsies/resections",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granulomatous gastritis is a subtype of chronic gastritis and can be subclassified based on the etiology into infectious, noninfectious, and idiopathic granulomatous gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A specific cause can be identified in most patients found to have granulomatous gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2,6\">",
"     2,6",
"    </a>",
"    ]. The most likely causes vary by geography and ethnicity. Most cases of granulomatous gastritis in the western hemisphere are noninfectious in etiology with the most common cause in adults and children being Crohn's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In contrast, in developing countries, infectious causes of granulomatous gastritis, particularly infection with",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    ,",
"    <em>",
"    </em>",
"    are the most common cause of granulomatous gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a large Belgian series in which biopsies from 71 patients with granulomatous gastritis were reviewed, the most common causes of granulomatous gastritis were [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Crohn's disease (55 percent) or possible Crohn's disease (2 percent)",
"     </li>",
"     <li>",
"      Sarcoidosis (21 percent)",
"     </li>",
"     <li>",
"      Distal esophageal adenocarcinoma with chronic active gastritis (5 percent)",
"     </li>",
"     <li>",
"      MALT lymphoma (5 percent)",
"     </li>",
"     <li>",
"      Peptic ulcer complications (5 percent)",
"     </li>",
"     <li>",
"      Hypertrophic gastropathy and chronic active gastritis (2 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study from Korea, 18 of 22,643 patients (0.08 percent) were diagnosed with granulomatous gastritis over a six-year period (1997 to 2002) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/4\">",
"     4",
"    </a>",
"    ]. Of those, 72 percent had chronic gastritis with",
"    <em>",
"     H. pylori",
"    </em>",
"    , 11 percent had gastric adenocarcinomas, 5 percent had chronic gastritis without",
"    <em>",
"     H. pylori",
"    </em>",
"    , and 5 percent had Crohn's disease.",
"   </p>",
"   <p>",
"    A retrospective study of 23 children and 23 adults with granulomatous gastritis in a southern United States medical center demonstrated race-related differences in the etiologies of granulomatous gastritis. The adult population in this retrospective review was predominantly African American, and sarcoidosis was the most common cause of granulomatous gastritis rather than Crohn&rsquo;s disease as reported in other studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124999776\">",
"    <span class=\"h2\">",
"     Non-infectious causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Crohn's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although granulomatous gastritis is rare in Crohn&rsquo;s disease, this is the most common etiology of granulomatous gastritis in western countries. While clinically apparent gastric involvement is seen in 2 to 7 percent of patients with Crohn&rsquo;s disease, microscopic involvement may be detected in up to 75 percent of patients with Crohn&rsquo;s disease and endoscopically normal mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individuals with Crohn&rsquo;s disease of the stomach may have focally enhanced gastritis (FEG), a focal inflammatory lesion composed of lymphocytes, histiocytes, and admixed granulocytes (which involve either one or a few adjacent foveolae) in a background of normal gastric mucosa. FEG is more frequent in the gastric antrum than in the gastric body [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/11\">",
"     11",
"    </a>",
"    ]. Lymphocytic gastritis may also be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/6\">",
"     6",
"    </a>",
"    ]. Approximately 10 to 33 percent of these patients also have",
"    <em>",
"     H. pylori",
"    </em>",
"    and chronic active gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Granulomas are present in approximately one-third of individuals with Crohn&rsquo;s disease and microscopic gastric involvement. The rate may be higher with increased tissue sampling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/12\">",
"     12",
"    </a>",
"    ]. These granulomas are mucosal but are sharply separated from the foveolar epithelium and often poorly formed (",
"    <a class=\"graphic graphic_picture graphicRef61180 \" href=\"mobipreview.htm?24/5/24662\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Granulomatous gastritis may be present in patients with known Crohn&rsquo;s colitis or ileitis or may be the first manifestation of Crohn&rsquo;s disease, particularly in children. In patients with the histopathologic findings of FEG or granulomas, or symptoms suggestive of inflammatory bowel disease, a search for intestinal Crohn's disease should be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=see_link\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Sarcoidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric granulomas found in patients with systemic sarcoidosis are usually asymptomatic. Subclinical gastrointestinal tract involvement has been identified in 5 to 10 percent of patients with systemic sarcoidosis, while symptomatic disease has been reported in less than one percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/14/17638?source=see_link\">",
"     \"Gastrointestinal sarcoidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare causes of granulomatous gastritis include tumors (upper GI tract adenocarcinoma and MALT lymphoma), vasculitides (eg, granulomatosis with polyangiitis [Wegener&rsquo;s granulomatosis]), drugs (eg, cocaine and carbimazole), xanthogranulomatous gastritis, foreign body reactions to stomach contents within an ulcer repair zone, surgical material (eg, suture), crystalline drugs or agents (eg, antacids containing magnesium, aluminium, and silicon) or endogenous materials (mucin, lipid, or crystalline material), Langerhans cell histiocytosis (which is more common in childhood), and chronic granulomatous disease (which is also more common in childhood and adolescence) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17386?source=see_link\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/36/10826?source=see_link\">",
"     \"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H124999878\">",
"    <span class=\"h2\">",
"     Infectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although an association with granulomatous gastritis and",
"    <em>",
"     H. pylori",
"    </em>",
"    has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/3,4,15,16\">",
"     3,4,15,16",
"    </a>",
"    ], it is now accepted that evidence does not support",
"    <em>",
"     H. pylori",
"    </em>",
"    as an etiologic agent in most cases of granulomatous gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/14,17\">",
"     14,17",
"    </a>",
"    ]. In a review of 18,000 gastric biopsies,",
"    <em>",
"     H. pylori",
"    </em>",
"    was only identified in 6 of 16 granulomatous biopsies, possibly an incidental finding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/18\">",
"     18",
"    </a>",
"    ]. In a subsequent series of 71 patients, 92 percent of biopsies contained",
"    <em>",
"     H. pylori",
"    </em>",
"    ; however, many diverse etiologies for the associated granulomatous gastritis were also found [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While",
"    <em>",
"     H. pylori",
"    </em>",
"    infection with related chronic active gastritis may be responsible for rare cases of granulomatous gastritis, a search for other causes of granulomata must be undertaken despite the presence of",
"    <em>",
"     H. pylori",
"    </em>",
"    organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/1,18\">",
"     1,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other infections that can cause granulomatous gastritis include tuberculosis, tertiary syphilis (gumma), Whipple's disease, various fungal infections including cryptococcus, anisakiasis caused by ingestion of raw fish, taeniasis, other parasitic worms and schistosomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20826?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of late syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/35/11833?source=see_link\">",
"     \"Whipple's disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/26/4519?source=see_link\">",
"     \"Intestinal tapeworms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/38/15977?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical features of schistosomiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/14/7398?source=see_link\">",
"     \"Diagnosis of schistosomiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Idiopathic granulomatous gastritis (IGG)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In up to 25 percent of cases a cause of granulomatous gastritis cannot be identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2\">",
"     2",
"    </a>",
"    ]. These patients are considered to have idiopathic or isolated granulomatous gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/14,19\">",
"     14,19",
"    </a>",
"    ]. The clinical importance of idiopathic granulomatous gastritis and its existence as a distinctive condition are uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. It is possible that \"idiopathic\" granulomatous gastritis represents a nonspecific inflammatory reaction to an as yet unknown or undiscovered agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Some of these patients may also eventually be diagnosed with a known cause (ie, sarcoidosis). Therefore the use of descriptive terminology granulomatous gastritis of uncertain etiology rather than the term idiopathic granulomatous gastritis as a specific diagnosis has been suggested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granulomatous gastritis encompasses a broad spectrum of histopathologic features ranging from vague, ill defined collections of",
"    <span class=\"nowrap\">",
"     mucosal/submucosal",
"    </span>",
"    macrophages to fully formed granulomas with giant cells and palisades of histiocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Granuloma type",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granulomas may be non-caseating, caseating, or necrotizing. Caseating necrosis is usually associated with an infectious etiology which may be fungal or bacterial (",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    , atypical mycobacteria, histoplasmosis). Well defined epithelioid granulomas with a circumscribed solid appearance are commonly seen in sarcoidosis. Non-caseating granulomas are seen with",
"    <em>",
"     H. pylori",
"    </em>",
"    and Crohn's disease. Necrotizing granulomas, especially if associated with vasculitis, suggest granulomatosis with polyangiitis.",
"   </p>",
"   <p>",
"    The morphologic features of the granulomas may yield a clue to the etiology; however, in many cases the granulomas are morphologically nonspecific. Special stains are needed to rule out infectious etiologies (acid fast stains and silver impregnation stains, or specific immunohistochemical stains for designated",
"    <span class=\"nowrap\">",
"     organisms/fungi).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Granuloma environment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tissue surrounding the granulomas may also contain a clue to the etiology of the granulomatous gastritis. In Crohn's disease, the gastric mucosa may demonstrate focally enhanced gastritis, and in granulomatous disease associated with",
"    <em>",
"     H. pylori",
"    </em>",
"    , a chronic active gastritis or chronic atrophic gastritis may be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/17\">",
"     17",
"    </a>",
"    ]. An infiltrate rich in eosinophils is suggestive of a parasitic infection. The presence of isolated compact granulomas sometimes surrounded by lymphocytes in otherwise normal appearing mucosa is suggestive of sarcoidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/17\">",
"     17",
"    </a>",
"    ]. Gastric involvement in syphilis is characterized by a dense lymphoplasmacytic and granulomatous infiltrate often in a perivascular distribution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diseases with granulomatous infiltrates, instead of well formed granulomas, may have specific morphologic features, such as Langerhans cell histiocytosis, in which the macrophages are reniform and are CD1a-positive. The presence of necrotizing vasculitis is suggestive of granulomatosis with polyangiitis (Wegener&rsquo;s granulomatosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7873253\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may be asymptomatic or present with epigastric abdominal pain. Nausea, vomiting, and weight loss may result from gastric outlet obstruction. Patients with concomitant intestinal involvement may have diarrhea. Upper gastrointestinal bleeding, although rare, has been reported in patients with sarcoidosis and may occasionally be massive and fatal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Other clinical features vary based on the underlying etiology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/14/17638?source=see_link\">",
"     \"Gastrointestinal sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25752?source=see_link\">",
"     \"Sarcoid: Muscle, bone, and vascular disease manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=see_link\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/35/11833?source=see_link\">",
"     \"Whipple's disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of granulomatous gastritis is based on the histopathologic evaluation of gastric tissue. Granulomatous gastritis is considered to be present when there is a nodular, fairly circumscribed collection of epithelioid histiocytes, often mixed with lymphocytes and plasma infiltrate in the stomach. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Histopathologic features'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H209914483\">",
"    <span class=\"h2\">",
"     Evaluation to determine the underlying etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following approach may be used to determine the underlying cause of granulomatous gastritis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A clinical history should include a history of residence in or travel to areas endemic for certain infectious diseases (eg,",
"      <em>",
"       Mycobacterium tuberculosis",
"      </em>",
"      , atypical mycobacteria, histoplasmosis,",
"      <em>",
"       H. pylori,",
"      </em>",
"      schistosomiasis, teniasis), high risk behaviors (eg, cocaine, syphilis), medications (eg, antacids), pulmonary or systemic symptoms (eg, sarcoidosis, Whipple&rsquo;s disease, MALT lymphoma),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      evidence of lower gastrointestinal symptoms (eg, Crohn&rsquo;s disease, Whipple&rsquo;s disease).",
"     </li>",
"     <li>",
"      A careful endoscopic inspection of the stomach with biopsies to map the extent of the disease process should be undertaken. The endoscopic appearance of granulomatous gastritis may reveal erythema, erosions, ulcers, rugal hypertrophy or luminal obstruction simulating malignancy or be completely normal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33702/abstract/18,26\">",
"       18,26",
"      </a>",
"      ]. Note should be made of the presence of suture material. Multiple biopsies of the gastric mucosa should be obtained to increase diagnostic yield, as granulomas may be present in endoscopically normal mucosa.",
"     </li>",
"     <li>",
"      Histopathological examination should include hematoxylin and eosin stains to evaluate the number of granulomas, location of the granulomas, nature of the inflammatory background of surrounding gastric mucosa. Certain histopathologic features may be suggestive of the underlying etiology. For example, the presence of caseating necrosis may be due to fungal or bacterial infections (",
"      <em>",
"       Mycobacterium tuberculosis",
"      </em>",
"      , atypical mycobacteria, histoplasmosis). The presence of well defined epithelioid granulomas surrounded by normal appearing mucosa is suggestive of sarcoidosis. Non-caseating granulomas are seen with",
"      <em>",
"       H. pylori",
"      </em>",
"      and Crohn's disease. Necrotizing granulomas, especially if associated with vasculitis, suggest granulomatosis with polyangiitis features. In Crohn's disease, the gastric mucosa may demonstrate focally enhanced gastritis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Histopathologic features'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Special stains should be performed for specific",
"      <span class=\"nowrap\">",
"       bacteria/fungi",
"      </span>",
"      (acid fast stains and silver impregnation stains, or specific immunohistochemical stains for designated",
"      <span class=\"nowrap\">",
"       organisms/fungi).",
"      </span>",
"      Polarization should be performed to look for birefringent material (foreign body).",
"     </li>",
"     <li>",
"      Laboratory testing, colonoscopy, and imaging studies should be based on clinical suspicion (eg, chest radiography for tuberculosis and sarcoidosis, angiotensin converting enzyme level for sarcoidosis, serum antineutrophil cytoplasmic antibodies for granulomatosis with polyangiitis, and serologic tests for syphilis). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20826?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21914?source=see_link\">",
"       \"Clinical manifestations and diagnosis of sarcoidosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17386?source=see_link\">",
"       \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39624?source=see_link\">",
"       \"Diagnostic testing for syphilis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A granuloma is an organized aggregation of combined histiocytic, lymphocytic, and plasma infiltrate (granulomatous inflammation). When this organized collection of cells is identified in the stomach, it is referred to as granulomatous gastritis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Granulomatous gastritis encompasses a broad spectrum of histopathologic features ranging from vague, ill defined collections of",
"      <span class=\"nowrap\">",
"       mucosal/submucosal",
"      </span>",
"      macrophages to fully formed granulomas with giant cells and palisades of histiocytes. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Histopathologic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Granulomatous gastritis is subtype of chronic gastritis that may be infectious, non-infectious, or idiopathic in etiology. Granulomatous gastritis is rare, with an incidence of 0.08 to 0.35 percent of gastritis cases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In developed countries, the most common causes of granulomatous gastritis are Crohn's disease and sarcoidosis, while in developing countries, infectious causes are more common.",
"      <br/>",
"      <br/>",
"      The cause of granulomatous gastritis cannot be identified in up to 25 percent of patients. These individuals are considered to have \"granulomatous gastritis of uncertain etiology\". Some of these patients will eventually present with an identifiable etiology for the granulomatous gastritis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of granulomatous gastritis is based on the histopathologic evaluation of gastric tissue. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Determining the etiology of granulomatous gastritis requires a detailed clinical history and endoscopic evaluation including biopsies for histopathological examination that includes hematoxylin and eosin stains. Special stains should be performed for designated",
"      <span class=\"nowrap\">",
"       organisms/fungi",
"      </span>",
"      (acid fast stains and silver impregnation stains, or specific immunohistochemical stains) and polarization. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Histopathologic features'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Additional laboratory testing, colonoscopy, and imaging studies should be performed to establish the etiology of granulomatous gastritis, based on the clinical setting. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/1\">",
"      Shapiro JL, Goldblum JR, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an \"idiopathic\" granulomatous gastritis? Am J Surg Pathol 1996; 20:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/2\">",
"      Ectors NL, Dixon MF, Geboes KJ, et al. Granulomatous gastritis: a morphological and diagnostic approach. Histopathology 1993; 23:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/3\">",
"      Maeng L, Lee A, Choi K, et al. Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol 2004; 28:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/4\">",
"      FAHIMI HD, DEREN JJ, GOTTLIEB LS, ZAMCHECK N. ISOLATED GRANULOMATOUS GASTRITIS: ITS RELATIONSHIP TO DISSEMINATED SARCOIDOSIS AND REGIONAL ENTERITIS. Gastroenterology 1963; 45:161.",
"     </a>",
"    </li>",
"    <li>",
"     Genta RM. Granulomatous gastritis. In: Gastritis, Graham DY, Genta RM, Dixon MF (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/6\">",
"      Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med 2008; 132:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/7\">",
"      Kamani L, Mumtaz K, Azad NS, Jafri W. Granulomatous gastritis: a diagnostic dilemma? Singapore Med J 2008; 49:e222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/8\">",
"      Renault M, Goodier A, Subramony C, et al. Age-related differences in granulomatous gastritis: a retrospective, clinicopathological analysis. J Clin Pathol 2010; 63:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/9\">",
"      Oberhuber G, P&uuml;sp&ouml;k A, Oesterreicher C, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997; 112:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/10\">",
"      Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 1998; 22:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/11\">",
"      Xin W, Greenson JK. The clinical significance of focally enhanced gastritis. Am J Surg Pathol 2004; 28:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/12\">",
"      Owen DA. Gastritis and carditis. Mod Pathol 2003; 16:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/13\">",
"      Vahid B, Spodik M, Braun KN, et al. Sarcoidosis of gastrointestinal tract: a rare disease. Dig Dis Sci 2007; 52:3316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/14\">",
"      Lauwers GY. Gastritis: beyond Helicobacter pylori. Int J Surg Pathol 2010; 18:28S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/15\">",
"      Ozturk Y, Buyukgebiz B, Ozer E, et al. Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy. J Pediatr Gastroenterol Nutr 2004; 39:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/16\">",
"      Miyamoto M, Haruma K, Yoshihara M, et al. Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori. J Gastroenterol 2003; 38:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/17\">",
"      Genta RM, Lash RH. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find. Am J Surg Pathol 2010; 34:e25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/18\">",
"      Srivastava A, Lauwers GY. Pathology of non-infective gastritis. Histopathology 2007; 50:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/19\">",
"      Lauwers GY, Fujita H, Nagata K, Shimizu M. Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol 2010; 45:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/20\">",
"      Sandmeier D, Bouzourene H. Does idiopathic granulomatous gastritis exist? Histopathology 2005; 46:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/21\">",
"      Besses C, Sans-Sabrafen J, Badia X, et al. Ulceroinfiltrative syphilitic gastropathy: silver stain diagnosis from biopsy specimen. Am J Gastroenterol 1987; 82:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/22\">",
"      Beckman JW, Schuman BM. Antral gastritis and ulceration in a patient with secondary syphilis. Gastrointest Endosc 1986; 32:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/23\">",
"      Anai H, Okada Y, Okubo K, et al. Gastric syphilis simulating linitis plastica type of gastric cancer. Gastrointest Endosc 1990; 36:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/24\">",
"      Munker M, Sharma OP. Fatal gastrointestinal haemorrhage in sarcoidosis: a previously unreported occurrence. Sarcoidosis 1987; 4:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/25\">",
"      Akinyemi E, Rohewal U, Tangorra M, Abdullah M. Gastric sarcoidosis. J Natl Med Assoc 2006; 98:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33702/abstract/26\">",
"      Gumaste VV, Janowitz HD, Waye JD. Granulomatous gastritis: a case report and review of the literature. Am J Gastroenterol 1989; 84:1315.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-29CCF0041E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33702=[""].join("\n");
var outline_f32_58_33702=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H124999776\">",
"      Non-infectious causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Other causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H124999878\">",
"      Infectious causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Idiopathic granulomatous gastritis (IGG)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HISTOPATHOLOGIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Granuloma type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Granuloma environment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7873253\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H209914483\">",
"      Evaluation to determine the underlying etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/9\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/9|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/5/24662\" title=\"picture 1\">",
"      Granuloma giant cell Crohns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/22/30055?source=related_link\">",
"      Acute and chronic gastritis due to Helicobacter pylori",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/36/10826?source=related_link\">",
"      Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/30/31205?source=related_link\">",
"      Classification and diagnosis of gastritis and gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20826?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/14/7398?source=related_link\">",
"      Diagnosis of schistosomiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/38/15977?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical features of schistosomiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/14/17638?source=related_link\">",
"      Gastrointestinal sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/26/4519?source=related_link\">",
"      Intestinal tapeworms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of late syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25752?source=related_link\">",
"      Sarcoid: Muscle, bone, and vascular disease manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/35/11833?source=related_link\">",
"      Whipple's disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_58_33703="Treatment of rabies";
var content_f32_58_33703=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of rabies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Charles E Rupprecht, VMD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33703/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/58/33703/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6182611\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is one of the oldest and most feared human diseases with the highest case fatality rate of any infectious disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/1\">",
"     1",
"    </a>",
"    ]. The clinical illness is characterized by motor weakness, paresthesias, and acute, progressive encephalitis with coma and death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the development of the first",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    in 1885, the World Health Organization estimates that between 30,000 and 70,000 people die worldwide of rabies each year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/3\">",
"     3",
"    </a>",
"    ]. Most of these deaths occur in developing countries because of inadequate control of rabies in domesticated animals. In the United States, there has been an average of three fatal human cases per year since 1980, mainly related to bat-associated rabies viruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/4-11\">",
"     4-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no proven therapy for rabies. The management of the patient and the use of an experimental protocol will be reviewed here. The epidemiology, clinical manifestations and diagnosis of rabies is found elsewhere. Rabies prophylaxis and immunization guidelines are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/39/20088?source=see_link\">",
"     \"When to use rabies prophylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5102478\">",
"    <span class=\"h1\">",
"     VIROLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Rhabdoviridae family includes rod-shaped, single stranded RNA viruses. Rabies virus is one highly neurotropic virus in the Lyssavirus genus, which infects animals and humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/12\">",
"     12",
"    </a>",
"    ]. At least 11 other rabies-related viruses can cause fatal encephalitis that are clinically indistinguishable from classical rabies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]; for example, two patients died in Australia with a rabies illness that was attributed to Australian bat Lyssavirus (ABLV), first isolated in 1996 from a flying fox [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H529400\">",
"    <span class=\"h1\">",
"     MILWAUKEE PROTOCOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;An experimental protocol called the Milwaukee protocol has been proposed for use in patients with rabies, as described below. We do not recommend the general use of this protocol for the treatment of rabies patients pending further data. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3283944\">",
"    <span class=\"h2\">",
"     Rationale for protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven antiviral therapy and no licensed anti-viral drugs for rabies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2\">",
"     2",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     Ribavirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    have in vitro activity against rabies virus, but have not been formally studied in clinical trials in endemic areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In light of the known neurotransmitter imbalance and severe dysautonomia seen in association with rabies, some researchers have suggested therapeutic interventions designed to protect the brain from injury, while waiting for the host immune response to clear the virus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/18\">",
"     18",
"    </a>",
"    ]. This potential therapeutic strategy is based on the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Animal data suggest a possible role for humoral immunity in clearance of rabies virus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/19\">",
"       19",
"      </a>",
"      ]. For example, animals have demonstrated clinical illness following rabies virus inoculation, with subsequent recovery after the development of rabies virus-specific antibodies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/20\">",
"       20",
"      </a>",
"      ]. In addition, rabies virus has not been isolated from animals who survived inoculation with rabies virus, suggesting the possibility of immunologic clearance.",
"     </li>",
"     <li>",
"      Death may be directly related to other causal pathways, such as severe autonomic instability, cerebral vasospasm, and deficiencies in tetrahydrobiopterin, an essential cofactor for neurotransmitter synthesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rabies virus infection confers little viral or immune-mediated cytopathic effect on brain tissue, suggesting the possibility of recovery. Pathologic examination of brain tissue from patients with rabies often demonstrates relatively minor changes related to rabies virus per se; other histologic findings are usually related to secondary complications (eg, hypotension, anoxia, vasospasm) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/18,22\">",
"       18,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on these observations the following strategic interventions (known collectively as the &ldquo;Milwaukee protocol&rdquo;) have been suggested by researchers at the Medical College of Wisconsin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/21,23-25\">",
"     21,23-25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Induction of therapeutic coma to reduce putative excitotoxicity (the proposed pathologic actions of viral-induced excessive excitatory amino acids or neurotransmitters upon neural cells), brain metabolism, and autonomic reactivity, which can be severe and life-threatening. One suggested therapeutic agent is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      , a dissociative anesthetic agent and a noncompetitive antagonist of the N-methyl-D-aspartate receptor; at high concentrations, ketamine may also inhibit rabies virus replication in vitro or in animal models. Benzodiazepines and barbiturates have also been used in this protocol [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/26\">",
"       26",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      Intensive supportive care",
"     </li>",
"     <li>",
"      Use of drugs with potential antiviral activity (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"       amantadine",
"      </a>",
"      ) &nbsp;",
"     </li>",
"     <li>",
"      Therapeutic blockade of cerebral artery spasm",
"     </li>",
"     <li>",
"      Avoidance of passive or active immunization with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"       rabies vaccine",
"      </a>",
"      or rabies immunoglobulin, because of theoretical concerns regarding interference with the native immune response and uncertainty about penetration into the central nervous system",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H530309\">",
"    <span class=\"h1\">",
"     CLINICAL USE OF THE MILWAUKEE PROTOCOL",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5102970\">",
"    <span class=\"h2\">",
"     Case reports of survival from rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three patients who survived rabies virus infection, without any history of pre-exposure prophylaxis, are described here. All infections occurred in young adolescents who had serologic evidence of rabies virus-specific antibody in serum and cerebrospinal fluid (CSF); none had evidence of rabies virus antigens or viral RNA in any clinical samples. Two of the three patients were treated with the &ldquo;Milwaukee protocol&rdquo; (described below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8915620\">",
"    <span class=\"h3\">",
"     Case 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 15-year-old female was bitten by a bat on her left hand. One month later she presented to the hospital with a history of fever, nausea and vomiting, diplopia, ataxia, and weakness of the left leg and paresthesias of the left hand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/26\">",
"     26",
"    </a>",
"    ]. Samples of serum, CSF, nuchal skin, and saliva were submitted for testing and rabies virus-specific antibody was confirmed in serum and CSF by the Centers for Disease Control and Prevention (CDC). Attempts to isolate rabies virus or to detect viral antigen or viral RNA from skin biopsies and saliva samples were unsuccessful.",
"   </p>",
"   <p>",
"    After extensive counseling with the family regarding the diagnosis, an investigational treatment protocol (ie, the Milwaukee protocol) was implemented with the family's consent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       Ketamine",
"      </a>",
"      was administered at 2",
"      <span class=\"nowrap\">",
"       mg/kg/hour",
"      </span>",
"      with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      at 1 to 3.5",
"      <span class=\"nowrap\">",
"       mg/kg/hour",
"      </span>",
"      to suppress background cerebral activity on electroencephalography. High doses of benzodiazepines with supplemental barbiturates were necessary to maintain burst suppression.",
"     </li>",
"     <li>",
"      High-dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      was administered on the third hospital day with a loading dose of 33",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      followed by a maintenance dose of 16",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      every six hours; this was later reduced during the hospital course because of significant adverse events (eg, anemia, mitochondrial toxicity, pancreatitis). &nbsp;",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"       Amantadine",
"      </a>",
"      was given enterally at 200 mg per day for one week [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Serial CSF examinations demonstrated an increase in anti-rabies virus IgG by immunofluorescent assay from 1:32 to 1:2048. On the 27th day of illness, the patient was extubated and eventually discharged home, approximately two months after admission. In a clinic visit 131 days after her initial hospitalization, she was interactive but her speech was dysarthric, her gait lurching, and she had fine-motor difficulties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/23\">",
"     23",
"    </a>",
"    ]. Follow-up 18 and 27 months after her initial exposure demonstrated resolution of choreoathetosis and significant improvement in her dysarthria and gait [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8915649\">",
"    <span class=\"h3\">",
"     Case 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;An 8-year-old girl presented with difficulty swallowing, generalized weakness and confusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/28\">",
"     28",
"    </a>",
"    ]. Over the next few days the patient developed ascending flaccid paralysis, a decreased level of consciousness, and fever. Rabies virus-specific antibodies (IgM and IgG) were demonstrated in the serum by indirect fluorescent antibody testing. On day 9 the patient was sedated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    was administered for its potential antiviral activity. She was also given",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/20/16710?source=see_link\">",
"     nimodipine",
"    </a>",
"    to prevent cerebral artery vasospasm. The patient developed autonomic instability and had episodes of supraventricular tachycardia requiring adenosine. After the 13",
"    <sup>",
"     th",
"    </sup>",
"    day of hospitalization the patient began to move her head and extremities and was eventually extubated. She had no signs of cognitive impairment and was left with a residual foot drop as her only neurologic deficit. &nbsp;",
"   </p>",
"   <p>",
"    Laboratory testing demonstrated rabies virus-specific antibodies in multiple serum and CSF samples; however, no rabies virus antigens or RNA were detected in saliva, serum, or nuchal biopsy tissue. The source of the rabies virus exposure was unclear, but suggested contact with feral cats near her school.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3284070\">",
"    <span class=\"h3\">",
"     Clinical implications",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, two patients who survived rabies were treated with the Milwaukee protocol. Of note, both of these patients had evidence of rabies virus-specific antibodies in serum and CSF at clinical presentation but no viral antigens or RNA were identified despite careful investigation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/23\">",
"     23",
"    </a>",
"    ]. The survival of these two patients could have been related to [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The therapeutic intervention itself",
"     </li>",
"     <li>",
"      Infection with a low concentration or a less virulent viral rabies virus variant",
"     </li>",
"     <li>",
"      A rare host genetic polymorphism that facilitated recovery from rabies virus infection",
"     </li>",
"     <li>",
"      Cross-reactive antibodies to another as of yet unidentified neurotropic virus in the Lyssavirus genus that may be less virulent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H529635\">",
"    <span class=\"h2\">",
"     Case reports of therapeutic failure of the Milwaukee protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of the Milwaukee protocol has been unsuccessful in several other reports; viral RNA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    viral antigens were isolated from all of these cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/14,24,31-37\">",
"     14,24,31-37",
"    </a>",
"    ] except for one patient who had limited specimens taken for analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/34\">",
"     34",
"    </a>",
"    ]. Some, but not all, of these patients had evidence of rabies virus-specific antibodies. Three illustrative case reports are discussed below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 33-year-old Thai male with a history of a dog bite presented with a four-day history of fever, paresthesias of his left arm, and phobic spasms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/35\">",
"       35",
"      </a>",
"      ]. On presentation to the hospital, rabies virus RNA was found in the patient&rsquo;s hair follicles using nucleic acid sequence-based amplification. The Milwaukee Protocol was initiated immediately while the patient was fully conscious, but the patient died eight days later. No rabies virus-specific antibodies were documented during his clinical course in serum or CSF. At autopsy, rabies virus antigens were demonstrated in brain and spinal cord tissues.",
"     </li>",
"     <li>",
"      One report documented the use of this protocol in two patients with rabies within 3 and 14 days from onset of symptoms, respectively; however both patients died [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A patient with renal failure received a kidney transplant from a patient who had undiagnosed rabies at the time of death. The Milwaukee protocol was initiated 12 days after onset of hydrophobia; the patient died on day 80 after transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/34\">",
"       34",
"      </a>",
"      ]. Only saliva and corneal swabs were sent for laboratory testing; no evidence of rabies virus antigens or RNA was found in these specimens.",
"     </li>",
"     <li>",
"      A soldier, who likely acquired rabies through a dog bite in Afghanistan, was treated with the Milwaukee protocol on day two of hospitalization and day six of symptoms; life support was withdrawn on day 12 when severe intracerebral hemorrhage was evident [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H530396\">",
"    <span class=\"h1\">",
"     RABIES SURVIVAL WITHOUT MILWAUKEE PROTOCOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are scattered reports of patient survival after suspected rabies; most of these patients were diagnosed serologically and no virus isolates, antigens, or RNA were obtained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. One patient is described below.",
"   </p>",
"   <p>",
"    A 17-year-old girl presented with headache, photophobia and paresthesias of her face and forearms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/40\">",
"     40",
"    </a>",
"    ]. Cerebrospinal fluid (CSF) examination showed 163 white blood",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    with 97 percent lymphocytes. The patient was discharged home when her symptoms resolved after three days. The patient was seen again one week later with similar symptoms in addition to new motor weakness and agitation. A repeat lumbar puncture demonstrated elevated intracranial pressure and ongoing lymphocytic pleocytosis. She never developed autonomic instability or hydrophobia.",
"   </p>",
"   <p>",
"    A history of bat exposure in a cave approximately two months prior to illness was obtained. Subsequently, serum and CSF samples for rabies testing were obtained that demonstrated rabies virus antibodies by indirect fluorescent antibody testing. However, no viral antigens or viral RNA were isolated from saliva or nuchal skin biopsy tissue. The patient returned for recurring headache on two other occasions, but she was not rehospitalized and was lost to follow-up. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H529306\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF PATIENTS WITH RABIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2596020\">",
"    <span class=\"h2\">",
"     Palliative care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of symptomatic rabies in unvaccinated patients is usually palliative. At a minimum, palliative therapy should focus on comfort care, pain control, and sedation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/52/28490?source=see_link\">",
"     \"Overview of comprehensive patient assessment in palliative care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6597382\">",
"    <span class=\"h2\">",
"     Milwaukee protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;An expert panel has suggested that in unusual circumstances, an aggressive approach for the treatment of rabies (such as the Milwaukee protocol) may be implemented. The panel suggested that a more aggressive approach may be considered for a patient who has presented as an early stage of disease, the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    had been administered before onset of clinical rabies, or the host is otherwise healthy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In light of the cases of rabies survival that have been reported, another favorable prognostic factor may be the presence of rabies antibodies in the absence of viral antigen or viral RNA despite extensive investigation.",
"   </p>",
"   <p>",
"    Since several therapeutic failures have also been reported despite using the Milwaukee protocol, and at least one other patient has survived rabies without this intervention, the routine use of this therapeutic strategy is not suggested pending further clinical data. For the minority of patients who might be considered for this aggressive, experimental therapy, patients and their families should be advised of the high likelihood of death and the possibility of severe long-term neurologic deficits if the patient does survive. Components of the protocol include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    therapy and coma induction with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    , benzodiazepines, and barbiturates with EEG monitoring. Clinicians who wish to consider this investigative protocol should contact Dr. Rodney Willoughby at Children's Hospital of Wisconsin (414-266-2000) and visit their registry online at for more details (",
"    <a class=\"external\" href=\"file://www.mcw.edu/display/router.asp?docid=11655\">",
"     www.mcw.edu/display/router.asp?docid=11655",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H530707\">",
"    <span class=\"h2\">",
"     Antiviral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven effective antiviral therapy for rabies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2\">",
"     2",
"    </a>",
"    ]. There are some in vitro and animal data suggesting that interferon and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    may have activity against rabies virus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     Ribavirin",
"    </a>",
"    has in vitro activity against rabies virus, but was not effective in an animal model study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2,17\">",
"     2,17",
"    </a>",
"    ]. High-dose ribavirin is associated with significant toxicity such as severe anemia, pancreatitis and mitochondrial toxicity and is not advised.",
"   </p>",
"   <p>",
"    The few clinical reports that have been published on the use of interferon for rabies virus infection do not suggest efficacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The use of interferon and tribavirin, a nucleoside analog closely related to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    , did not influence the clinical outcome in four fully alert patients with an early diagnosis of rabies in Thailand who underwent treatment; of note, rabies virus was isolated in several clinical specimens from all patients and three of four did not have any evidence of rabies virus neutralizing antibodies before death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/42\">",
"     42",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Pending further data, we do not use antiviral therapy for the treatment of patients with rabies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2596122\">",
"    <span class=\"h2\">",
"     Immunization",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven role for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    or immune globulin in patients with established rabies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A few patients with a history of rabies virus exposure who received inadequate rabies prophylaxis have developed symptomatic disease and survived, most with neurologic deficits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/39,44\">",
"     39,44",
"    </a>",
"    ]. However, such patients should be considered examples of immunoprophylaxis failures, rather than examples of successful treatment. &nbsp;",
"   </p>",
"   <p>",
"    There are animal data to support the concept that proper rabies immunization shortly after the time of viral inoculation will decrease mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/45\">",
"     45",
"    </a>",
"    ]. Two patients who received rabies prophylaxis shortly after a suspected rabies exposure developed a clinical illness consistent with rabies at the time of completion of the rabies immunization series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/39,41\">",
"     39,41",
"    </a>",
"    ]. Although no virus or viral antigens were isolated, high levels of rabies virus-specific neutralizing antibodies were detected in cerebrospinal fluid; both patients had complete clinical recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/39,41\">",
"     39,41",
"    </a>",
"    ]. In one of these patients, rabies virus was isolated from the bat that bit the patient before onset of symptoms, strongly suggesting that the patient did have clinical rabies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/39/20088?source=see_link\">",
"     \"When to use rabies prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2596219\">",
"    <span class=\"h2\">",
"     Corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corticosteroid therapy is",
"    <strong>",
"     not",
"    </strong>",
"    recommended for rabies. In experimental rodent models, steroids increased mortality and decreased the incubation period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6182196\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2595893\">",
"    <span class=\"h2\">",
"     Hospital infection control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Barrier measures should be utilized by healthcare personnel when caring for a patient with rabies to minimize the need for postexposure prophylaxis. No cases of rabies virus transmission from patient to healthcare personnel have been reported.",
"   </p>",
"   <p>",
"    As mentioned above, no transmission of rabies virus has been documented from rabid patients to healthcare providers or household contacts or by fomites or environmental surfaces [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Routine delivery of healthcare to a patient with rabies is only considered a rabies virus exposure if mucous membranes or nonintact skin come in contact with potentially infectious body fluids or tissues. Standard infection control precautions would minimize the risk of any such exposure and should be routinely employed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6597267\">",
"    <span class=\"h2\">",
"     Rabies vaccine and immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is a preventable zoonotic disease with highly effective",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    and immune globulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/49\">",
"     49",
"    </a>",
"    ]. Given the lack of proven effective therapy, prevention of human rabies infection by the administration of either pre-exposure prophylaxis (for high-risk groups) or postexposure prophylaxis remains the cornerstone of management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33703/abstract/50\">",
"     50",
"    </a>",
"    ]. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/23/2418?source=see_link\">",
"       \"Patient information: Rabies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?29/55/30578?source=see_link\">",
"       \"Patient information: Rabies (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H530715\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rabies is one of the oldest and most feared human diseases with the highest case fatality rate of any infectious illness. Rabies is characterized by motor weakness, paresthesias, and encephalitis with coma and death. (See",
"      <a class=\"local\" href=\"#H6182611\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rabies is a neurotropic virus in the Lyssavirus genus, which infects mammals including humans. At least 11 other rabies-related viruses can cause fatal encephalitis that is clinically indistinguishable from classical rabies. (See",
"      <a class=\"local\" href=\"#H5102478\">",
"       'Virology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some researchers have suggested induction of a therapeutic coma to reduce brain metabolism and severe dysautonomia while waiting for immunologic recovery from rabies virus infection. This strategy, combined with antiviral medications with in vitro activity against rabies virus, has been termed the &ldquo;Milwaukee protocol&rdquo;. (See",
"      <a class=\"local\" href=\"#H529400\">",
"       'Milwaukee protocol'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two known patients have survived rabies virus infection after administration of the Milwaukee protocol. The survival of these two patients could have been related to: a) the therapeutic intervention, b) infection with lower concentrations of virus or less virulent rabies virus variants or a related unknown Lyssavirus, or c) a rare host genetic polymorphism. Since several therapeutic failures have also been reported with the Milwaukee protocol, and at least one patient has survived rabies virus infection without this intervention, the routine use of this therapeutic strategy is not suggested pending further data. All three patients had evidence of rabies antibody without detection of rabies virus or viral antigens. (See",
"      <a class=\"local\" href=\"#H6597382\">",
"       'Milwaukee protocol'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of symptomatic rabies in unvaccinated patients should be palliative. There is no proven role for antiviral therapy, corticosteroids,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"       rabies vaccine",
"      </a>",
"      or rabies immune globulin in patients with established rabies. Patients with rabies antibody, but who do not have evidence of rabies virus or viral antigens, may be the best candidates for intensive supportive care. (See",
"      <a class=\"local\" href=\"#H529306\">",
"       'Management of patients with rabies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After a suspected exposure, proper wound care and specific rabies postexposure prophylaxis with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/55/16246?source=see_link\">",
"       rabies vaccine",
"      </a>",
"      and rabies immune globulin is critically important for patient management since there is no proven antiviral therapy for rabies. (See",
"      <a class=\"local\" href=\"#H6182196\">",
"       'Prevention'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=see_link\">",
"       \"Rabies immune globulin and vaccine\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/39/20088?source=see_link\">",
"       \"When to use rabies prophylaxis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/1\">",
"      Warner CK, Zaki SR, Shieh WJ, et al. Laboratory investigation of human deaths from vampire bat rabies in Peru. Am J Trop Med Hyg 1999; 60:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/2\">",
"      Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis 2003; 36:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/3\">",
"      Knobel DL, Cleaveland S, Coleman PG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005; 83:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/4\">",
"      Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis 2002; 35:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/5\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Tennessee, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/6\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--California, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/7\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Iowa, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/8\">",
"      Centers for Disease Control and Prevention (CDC). First human death associated with raccoon rabies--Virginia, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/9\">",
"      Centers for Disease Control and Prevention (CDC). Human death associated with bat rabies--California, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/10\">",
"      Centers for Disease Control and Prevention (CDC). Investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/11\">",
"      Centers for Disease Control and Prevention (CDC). Update: investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:615.",
"     </a>",
"    </li>",
"    <li>",
"     Dietzgen RG, Calisher CH, Kurath G, et al. Family Rhabdoviridae. In: Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, King AM, Adams MJ, Carstens EB, Lefkowitz EJ.  (Eds), Elsevier, Oxford 2011. p.686.",
"    </li>",
"    <li>",
"     file://www.mja.com.au/public/issues/172_12_190600/hanna/hanna.html (Accessed on February 02, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/14\">",
"      van Thiel PP, de Bie RM, Eftimov F, et al. Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis 2009; 3:e428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/15\">",
"      Superti F, Seganti L, Pan&agrave; A, Orsi N. Effect of amantadine on rhabdovirus infection. Drugs Exp Clin Res 1985; 11:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/16\">",
"      Hilfenhaus J, Weinmann E, Majer M, et al. Administration of human interferon to rabies virus-infected monkeys after exposure. J Infect Dis 1977; 135:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/17\">",
"      Bussereau F, Picard M, Blancou J, Sureau P. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol 1988; 32:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/18\">",
"      Rubin RH, Sullivan L, Summers R, et al. A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J Infect Dis 1970; 122:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/19\">",
"      Miller A, Morse HC 3rd, Winkelstein J, Nathanson N. The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol 1978; 121:321.",
"     </a>",
"    </li>",
"    <li>",
"     Kitselman, CH. 1964. Recovery of a rat from experimentally induced rabies. J Amer Vet Med Assn 144:1113.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/21\">",
"      Willoughby RE, Roy-Burman A, Martin KW, et al. Generalised cranial artery spasm in human rabies. Dev Biol (Basel) 2008; 131:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/22\">",
"      Jackson AC. Rabies virus infection: an update. J Neurovirol 2003; 9:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/23\">",
"      Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352:2508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/24\">",
"      Aramburo A, Willoughby RE, Bollen AW, et al. Failure of the Milwaukee protocol in a child with rabies. Clin Infect Dis 2011; 53:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/25\">",
"      Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother 1992; 36:1750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/26\">",
"      Centers for Disease Control and Prevention (CDC). Recovery of a patient from clinical rabies--Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/27\">",
"      Hu WT, Willoughby RE Jr, Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma. N Engl J Med 2007; 357:945.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a1.htm?s_cid=mm6104a1_x.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/29\">",
"      Jackson AC. Recovery from rabies. N Engl J Med 2005; 352:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/30\">",
"      Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/31\">",
"      McDermid RC, Saxinger L, Lee B, et al. Human rabies encephalitis following bat exposure: failure of therapeutic coma. CMAJ 2008; 178:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/32\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Indiana and California, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/33\">",
"      Centers for Disease Control and Prevention (CDC). Human rabies--Alberta, Canada, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/34\">",
"      Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010; 50:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/35\">",
"      Hemachudha T, Sunsaneewitayakul B, Desudchit T, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol 2006; 12:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/36\">",
"      Hunter M, Johnson N, Hedderwick S, et al. Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol 2010; 82:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/37\">",
"      Wilde H, Hemachudha T, Jackson AC. Viewpoint: Management of human rabies. Trans R Soc Trop Med Hyg 2008; 102:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/38\">",
"      Centers for Disease Control and Prevention (CDC). Imported human rabies in a U.S. Army soldier - New York, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/39\">",
"      Hattwick MA, Weis TT, Stechschulte CJ, et al. Recovery from rabies. A case report. Ann Intern Med 1972; 76:931.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5907a1.htm (Accessed on March 05, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/41\">",
"      Porras C, Barboza JJ, Fuenzalida E, et al. Recovery from rabies in man. Ann Intern Med 1976; 85:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/42\">",
"      Warrell MJ, White NJ, Looareesuwan S, et al. Failure of interferon alfa and tribavirin in rabies encephalitis. BMJ 1989; 299:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/43\">",
"      Merigan TC, Baer GM, Winkler WG, et al. Human leukocyte interferon administration to patients with symptomatic and suspected rabies. Ann Neurol 1984; 16:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/44\">",
"      Alvarez L, Fajardo R, Lopez E, et al. Partial recovery from rabies in a nine-year-old boy. Pediatr Infect Dis J 1994; 13:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/45\">",
"      Baer GM, Cleary WF. A model in mice for the pathogenesis and treatment of rabies. J Infect Dis 1972; 125:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/46\">",
"      Enright JB, Franti CE, Frye FL, Behymer DE. The effects of corticosteroids on rabies in mice. Can J Microbiol 1970; 16:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/47\">",
"      Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/48\">",
"      Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987; 9:511.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. WHO expert consultation on rabies. WHO Tech Rep Ser 2005; Abstract 931, pg. 88.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33703/abstract/50\">",
"      Franka R, Rupprecht CE. Treatment of rabies in the 21st century: curing the incurable? Future Microbiol 2011; 6:1135.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16595 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-2A8E9B1E90-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33703=[""].join("\n");
var outline_f32_58_33703=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H530715\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6182611\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5102478\">",
"      VIROLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H529400\">",
"      MILWAUKEE PROTOCOL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3283944\">",
"      Rationale for protocol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H530309\">",
"      CLINICAL USE OF THE MILWAUKEE PROTOCOL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5102970\">",
"      Case reports of survival from rabies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8915620\">",
"      - Case 1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8915649\">",
"      - Case 2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3284070\">",
"      - Clinical implications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H529635\">",
"      Case reports of therapeutic failure of the Milwaukee protocol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H530396\">",
"      RABIES SURVIVAL WITHOUT MILWAUKEE PROTOCOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H529306\">",
"      MANAGEMENT OF PATIENTS WITH RABIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2596020\">",
"      Palliative care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6597382\">",
"      Milwaukee protocol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H530707\">",
"      Antiviral therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2596122\">",
"      Immunization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2596219\">",
"      Corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6182196\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2595893\">",
"      Hospital infection control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6597267\">",
"      Rabies vaccine and immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H530715\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=related_link\">",
"      Clinical manifestations and diagnosis of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/52/28490?source=related_link\">",
"      Overview of comprehensive patient assessment in palliative care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?29/55/30578?source=related_link\">",
"      Patient information: Rabies (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/23/2418?source=related_link\">",
"      Patient information: Rabies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2393?source=related_link\">",
"      Rabies immune globulin and vaccine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/39/20088?source=related_link\">",
"      When to use rabies prophylaxis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_58_33704="Meta-analysis subgroup stratification II";
var content_f32_58_33704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 641px\">",
"   <div class=\"ttl\">",
"    Meta-analysis subgroup stratification, continued",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 621px; height: 451px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     THIS FIGURE IS A CONTINUATION OF THE FIGURE \"META-ANALYSIS SUBGROUP STRATIFICIATION I\".",
"    </strong>",
"    <br>",
"     This meta-analysis examined the effect of corticosteroids on mortality in patients with sepsis. In the first analysis, the summary estimate for the overall effect was a risk ratio of 0.87 but the 95% CI ranged from 0.74 to 1.01, yielding an overall non-significant effect. Nevertheless, the lower boundary of the confidence interval suggests as much as a 26 percent reduction in mortality from corticosteroids, suggesting that there may be a benefit, but the results were not sufficiently precise to detect it. In addition, tests for heterogeneity suggested that the studies were substantially heterogeneous. Clinical domain experts pointed out that there may be a difference in studies using short course of high-dose corticosteroids versus long courses of low-dose corticosteroids. When the analysis was repeated using such a stratification, the summary effect size (risk ratio 0.84) (95% CI 0.72-0.97) reached statistical significance. Furthermore, results of the low-dose trials were relatively homogeneous compared with the preceding combined analysis.",
"     <br>",
"      Size of the data markers indicates weight of the study.",
"      <div class=\"footnotes\">",
"       CI: confidence interval; VASSCSG: Veterans Administration Systemic Sepsis Cooperative Study Group.",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Annane D, Bellissant E, Bollaert P, et al. Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults. JAMA 2009; 301:2362. Copyright &copy; 2009 American Medical Association. All rights reserved.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33704=[""].join("\n");
var outline_f32_58_33704=null;
var title_f32_58_33705="Infected eczema hand";
var content_f32_58_33705=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74056%7EPC%2F62234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74056%7EPC%2F62234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Staphylococcus aureus infection in atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pustules and honey-colored crusting are seen on the dorsal hand of this patient with infected atopic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Morelli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Staphylococcus aureus infection in atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Honey colored crusts are seen on the postauricular skin of this patient with infected atopic dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Morelli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33705=[""].join("\n");
var outline_f32_58_33705=null;
var title_f32_58_33706="Medical consultation for patients with hip fracture";
var content_f32_58_33706=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Medical consultation for patients with hip fracture",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     R Sean Morrison, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     Albert L Siu, MD, MSPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/58/33706/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/58/33706/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A total of 310,000 individuals were hospitalized with hip fractures in the United States in 2003 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/1\">",
"     1",
"    </a>",
"    ]. Worldwide, the incidence of hip fracture exceeds 1.6 million adults annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/2\">",
"     2",
"    </a>",
"    ]. Hip fracture rates among the elderly are declining in the US, possibly due to a concurrent rise in bisphosphonate use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hip fracture is associated with increased mortality rates for both the short-term (3 to 6 months) and long-term (5 to 10 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/4\">",
"     4",
"    </a>",
"    ]. A meta-analysis of prospective cohort studies found a five- to eight-fold increase in mortality rates within three months of fracture; this comparative increase relative to age-matched controls without a history of hip fracture lessened but persisted ten years following the fracture. Of those who survive to six months, only 60 percent recover their prefracture walking ability and only 50 percent recover their prefracture ability to perform activities of daily living [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hospital readmission rates after initial treatment for hip fracture range from 20 percent within 30 days of discharge (for a predominantly male group of veterans) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/6\">",
"     6",
"    </a>",
"    ] to 30 percent within six months (for a group predominantly female) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/7\">",
"     7",
"    </a>",
"    ]. Early readmission correlated with medical comorbidities including fluid and electrolyte problems, renal insufficiency, and underlying cardiac and pulmonary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hip fracture is typically considered a surgical disease. However, medical consultants are almost universally involved in the care of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/8\">",
"     8",
"    </a>",
"    ]. Medical consultation is associated with improved one year mortality for patients hospitalized with hip fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/9\">",
"     9",
"    </a>",
"    ]. This topic will review the most common decisions that medical consultants are asked to make in the care of the patient with hip fracture. In particular, we will focus on:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Timing of surgical intervention",
"     </li>",
"     <li>",
"      Prophylactic antibiotics",
"     </li>",
"     <li>",
"      Thromboembolic prophylaxis",
"     </li>",
"     <li>",
"      Prevention and management of delirium",
"     </li>",
"     <li>",
"      Assessment for underlying osteoporosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the diagnosis and management of the different types of hip fractures is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/31/18937?source=see_link\">",
"     \"Hip fractures in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TIMING OF SURGICAL INTERVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of surgery in patients with hip fracture, although ultimately set by the surgeon, is often dictated by the preoperative medical evaluation. Timing of the surgical intervention may have an important impact upon patient outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delay in surgical repair will result in postponement of full weight bearing status, leading to delayed functional recovery.",
"     </li>",
"     <li>",
"      Prolonged bed rest may increase the risk of medical complications, including deep venous thrombosis, pneumonia, urinary tract infection, and skin breakdown.",
"     </li>",
"     <li>",
"      Failure to stabilize coexisting medical conditions prior to surgery may increase the risk of postoperative complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of studies have examined the effect of operative timing on postsurgical outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/11-25\">",
"     11-25",
"    </a>",
"    ]. Interpretation of these data is complicated by the fact that many early studies were small and underpowered; and most did not control for the presence or severity of comorbidities or excluded patients with complicating medical conditions. Subsequent studies that did attempt to control for comorbidities had variable outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/18-25\">",
"     18-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of five prospective observational studies controlling for comorbidities, risk of mortality was lower among patients who had earlier surgery (within 72 hours) compared to delayed surgery (RR 0.81, 95% CI 0.68-0.96) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, two large studies that also controlled for comorbid conditions suggest that the time to surgery is primarily a marker of comorbidity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/22,25\">",
"       22,25",
"      </a>",
"      ]. In a retrospective study of 8383 patients, mortality rates were not different among patients who had surgery more than 96 hours after admission compared with patients who had surgery 24 to 48 hours after admission after adjusting for demographic characteristics and underlying medical problems [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/22\">",
"       22",
"      </a>",
"      ]. The risk of decubitus (pressure) ulcer was associated with delayed surgery (OR 2.2, 95% CI 1.6-3.1). A subsequent prospective cohort study of 2250 patients also found no association of in-hospital mortality or complications with surgical delays of &le;120 hours after adjusting for demographic characteristics and comorbid conditions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/25\">",
"       25",
"      </a>",
"      ]. However, higher rates of mortality and medical complications were associated with surgical delays &gt;120 hours, despite adjustment for these factors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients without active comorbid illness, surgical repair of hip fracture within the first 24 to 48 hours of admission is associated with a decrease in one-year mortality. A meta-analysis of 16 observational studies found that delay in operative repair beyond 48 hours was associated with significantly increased mortality at 30 days (OR 1.41, 95% CI 1.29-1.54) and at one year (OR 1.32, 95% CI 1.21-1.43) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/27\">",
"     27",
"    </a>",
"    ]. Early surgery is also associated with reduced pain and decreased length of stay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given available data, it seems reasonable to suggest the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perform early surgery (within 24 to 48 hours) in patients who are medically stable and do not have significant comorbid illness. Whether to operate immediately (eg, in the middle of the night) or to wait until a more convenient time is best determined by local hospital staffing and available support, rather than by the medical consultant.",
"     </li>",
"     <li>",
"      There does not seem to be substantial harm in waiting as long as 72 hours in patients with active comorbid medical illness, such as congestive heart failure, active infection (eg, pneumonia), unstable angina, or severe chronic obstructive pulmonary disease. Such individuals would likely benefit from more extensive preoperative evaluation and medical management of these conditions prior to repair of their fracture. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36810?source=see_link\">",
"       \"Estimation of cardiac risk prior to noncardiac surgery\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1162?source=see_link\">",
"       \"Evaluation of preoperative pulmonary risk\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/0/18440?source=see_link\">",
"       \"Perioperative heart failure in noncardiac surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Avoid delaying surgery beyond 72 hours.",
"     </li>",
"     <li>",
"      Unless contraindicated, thromboembolic prophylaxis should be instituted in patients who are awaiting surgery. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Thromboembolic prophylaxis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Aggressive decubitus ulcer prevention measures should be employed in patients in whom surgery is delayed beyond 24 to 48 hours. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/1/1049?source=see_link\">",
"       \"Prevention of pressure ulcers\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Preoperative morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hip fractures most commonly occur in frail older adults who have significant underlying comorbidity. In this context, questions arise about the risks of proceeding to surgery with uncorrected underlying abnormalities versus the risks of delaying surgery to perform a thorough preoperative assessment and maximize preoperative status.",
"   </p>",
"   <p>",
"    A prospective cohort study of patients older than 65 years hospitalized for unilateral hip fracture (nontraumatic, nonpathologic) identified major abnormalities (cardiac or respiratory failure, coagulopathy, electrolyte, or blood urea nitrogen irregularities) that were associated with increased postoperative or cardiopulmonary complications if uncorrected prior to surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/28\">",
"     28",
"    </a>",
"    ]. Validation of these criteria awaits further study. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PROPHYLACTIC ANTIBIOTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics are commonly administered to prevent wound infection following orthopedic procedures. Staphylococcus aureus was the most common organism isolated from multiple reports of wound infections in patients with hip fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/29-35\">",
"     29-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies addressing the use of antibiotic prophylaxis prior to repair of hip fracture have focused upon four main areas:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The efficacy of antibiotic therapy",
"     </li>",
"     <li>",
"      The timing of administration",
"     </li>",
"     <li>",
"      The duration of use",
"     </li>",
"     <li>",
"      The choice of agents",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Efficacy of antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review of 22 controlled trials of administration of prophylactic antibiotics in 8307 patients undergoing surgical management of hip and other long bone fractures found that antibiotic prophylaxis reduced the risk of deep wound infections by 60 percent and also reduced the risk of superficial wound infections, urinary tract infections, and respiratory tract infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/36\">",
"     36",
"    </a>",
"    ]. A meta-analysis of 15 placebo-controlled randomized trials in hip fracture surgery found that 20 patients would need to be treated with antibiotics to prevent one wound infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Timing of administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of administration of antibiotic prophylaxis has not been well studied. The only trial available to date is a cohort study of 2847 elective surgical hip procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients given their first dose of antibiotics less than two hours before surgery had the lowest incidence of postoperative infection; relative risk for infection increased with antibiotic administration within three hours following surgery (RR 2.4, 95% CI 0.9-7.9); 3 to 24 hours following surgery (RR 5.8, 2.6-12.3); or 2 to 24 hours",
"    <strong>",
"     before",
"    </strong>",
"    surgery (RR 6.7, 2.9-14.7). Thus, prophylactic antibiotics should be initiated within two hours prior to surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal course duration and number of antibiotic doses depends on the half-life of the antibiotic selected. A systematic review of randomized trials found that a single intravenous dose of an antibiotic that provides significant blood concentrations for 12 to 24 hours is as effective as multiple doses of agents with shorter half lives in preventing deep wound infections (RR 0.57, 95 % CI 0.2-1.6), superficial wound infections (RR 1.01, 0.35-2.9) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/36\">",
"     36",
"    </a>",
"    ], and urinary and respiratory tract infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/39\">",
"     39",
"    </a>",
"    ]. However, a single dose of a short-acting parenteral antibiotic was marginally less effective than multiple doses in preventing deep and superficial wound infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these results, antibiotic therapy should be given to provide antibiotic concentrations for 24 hours. Therapy may be provided as two or three doses of a shorter-acting drug or a single parenteral dose of an agent that provides a minimum inhibitory concentration over 12 to 24 hours. In general, shorter-acting drugs are less costly and have a more appropriate narrow spectrum. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Choice of agent'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Choice of agent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major pathogen in wound infections is Staphylococcus aureus. We suggest using a first generation cephalosporin (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    1 to 2 g intravenously Q 8 hours) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/40\">",
"     40",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    (1 g intravenously Q 12 hours) should be used in patients allergic to penicillins and cephalosporins and for those admitted to hospitals in which methicillin-resistant S. aureus and S. epidermis are a frequent cause of postoperative wound infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     THROMBOEMBOLIC PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous thromboembolism is one of the leading causes of postoperative morbidity and mortality in patients with hip fracture. Data regarding the risk of deep venous thrombosis (DVT) or acute pulmonary embolism (PE) in the absence of thromboprophylaxis are not available from recent trials, and older studies reflect risk in the setting of prolonged hospital stays and operative techniques that are more thrombogenic than those performed in more recent years. Older studies found, in the absence of thromboprophylaxis, venography-detected proximal DVT in 27 percent of patients following hip surgery and fatal pulmonary embolism in 0.4 to 7.5 percent of patients within three months of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/42\">",
"     42",
"    </a>",
"    ]. More recent data (based upon estimates extrapolated from the effectiveness of low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    and rates of DVT and PE in patients receiving low molecular weight heparin prophylaxis) suggest that, in the absence of prophylaxis, symptomatic DVT would occur in 1.8 percent and PE in 1.0 percent in the first 7 to 14 days following hip surgery, with an estimated 4.3 percent risk of symptomatic venous thromboembolic disease (VTE) occurring within 35 days of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Factors increasing the risk of venous thrombosis include advanced age, malignancy, previous venous thromboembolism, obesity, heart failure, paralysis, or the presence of an inhibitor deficiency state (",
"    <a class=\"graphic graphic_table graphicRef59759 \" href=\"mobipreview.htm?1/6/1132\">",
"     table 1",
"    </a>",
"    ). The most common inhibitor deficiency state is activated protein C resistance, a defect usually caused by a mutation in the gene coding for coagulation factor V and known as factor V Leiden. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28218?source=see_link\">",
"     \"Activated protein C resistance and factor V Leiden\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The high risk associated with orthopedic surgery results from a number of factors that contribute to venous stasis, including the supine position on the operating table and the anatomic positioning of the extremity. Intimal injury can occur as a consequence of the original trauma or surgical intervention, and transient release of tissue factors may further increase the risk of thrombosis.",
"   </p>",
"   <p>",
"    Although thromboembolic prophylaxis is a routine aspect of the care of the patient with hip fracture, questions remain regarding the optimal agent and the timing and duration of prophylaxis. The 2012 guidelines from the American College of Chest Physicians (ACCP) for the prevention of VTE in patients undergoing hip fracture surgery recommend prophylaxis using one of the following: low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    , low-dose unfractionated heparin, a vitamin K antagonist,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , or intermittent pneumatic leg compression; and give preference to low molecular weight heparin. All patients receiving anticoagulation should also be treated with intermittent pneumatic leg compression while they are unable to ambulate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Anticoagulant therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16118359\">",
"    <span class=\"h3\">",
"     Low molecular weight heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    reduces the risk of asymptomatic DVT by about 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. In one review, low molecular weight heparin was more effective than low-dose unfractionated heparin in reducing the risk of asymptomatic DVT (RR 0.80, 95% CI 0.73-0.88) in a pooled population of 23,000 patients, including 2800 who underwent either hip arthroplasty or hip fracture surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    fractions are available. Recommended regimens for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    are 30 mg subcutaneously every 12 hours or 40 mg once daily. Renal impairment needs to be taken into account when deciding on doses of low molecular weight heparin, especially in older patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/59/43961?source=see_link\">",
"     \"Low molecular weight heparin for venous thromboembolic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    can be given once or twice a day at a constant dose without laboratory monitoring and is associated with a lower incidence of thrombocytopenia than unfractionated heparin. As an example, one randomized, double-blind study of patients after hip surgery found that thrombocytopenia occurred in 9 of 332 patients (2.7 percent) receiving unfractionated heparin compared with none of 333 receiving low molecular weight heparin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=see_link\">",
"     \"Therapeutic use of heparin and low molecular weight heparin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies of low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    report the incidence of postoperative bleeding to be similar to bleeding associated with unfractionated heparin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. Low molecular weight heparin has been reported to cause bleeding or hematomas within the spinal column when used concurrently with spinal or epidural anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/45\">",
"     45",
"    </a>",
"    ]. Recommendations from the US Food and Drug Administration (FDA) are that patients receiving",
"    <span class=\"nowrap\">",
"     epidural/spinal",
"    </span>",
"    anesthesia who are treated with low molecular weight heparin should be monitored frequently for signs and symptoms of neurologic impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3052013\">",
"    <span class=\"h3\">",
"     Unfractionated heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low-dose unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (5000 units subcutaneously twice daily) has been the agent most frequently studied for thromboembolic prophylaxis. A meta-analysis of eight studies involving 623 patients undergoing general, orthopedic, or urologic surgery found that low-dose unfractionated heparin reduced the risk of deep venous thrombosis by 64 percent compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/46\">",
"     46",
"    </a>",
"    ]. In six trials looking at hip fracture surgery patients, the relative risk of asymptomatic DVT was decreased by 44 percent in patients treated with unfractionated heparin, compared to the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of thromboprophylaxis (31 trials including 3000 patients with hip fracture) found both low-dose unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    and low molecular weight heparin to be protective against DVT (RR 0.60, 95% CI 0.50-0.71), but could not determine the superiority of either form of heparin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/47\">",
"     47",
"    </a>",
"    ]. In another review, comparing estimates of prevention of VTE by low molecular weight heparin or low-dose unfractionated heparin in patients undergoing major orthopedic surgery, including hip fracture surgery, results suggested that low molecular weight would reduce symptomatic VTE slightly more than unfractionated heparin (13 and 16 episodes per 1000 patients, respectively) with equivalent bleeding risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anticoagulation with low-dose unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    slightly increases the risk of postoperative bleeding from a baseline rate of 2.9 percent in patients treated with placebo to 3.5 percent in patients treated with heparin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Fondaparinux",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    is a synthetic highly sulfated pentasaccharide that binds to antithrombin (AT) with a higher affinity than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , and causes a conformational change in AT that significantly increases the ability of AT to inactivate factor Xa. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/23/44408?source=see_link&amp;anchor=H11#H11\">",
"     \"Therapeutic use of fondaparinux\", section on 'Hip fracture surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the largest randomized trial of thromboprophylactic therapy to prevent VTE in patients with hip fracture, patients undergoing surgery for fracture of the upper third of the femur were randomly assigned to treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    (2.5 mg once daily starting 4 to 8 hours postoperatively) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    (40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    starting 12 hours preoperatively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/48\">",
"     48",
"    </a>",
"    ]. The incidence of venous thromboembolism (largely asymptomatic) by day 11 was significantly lower with fondaparinux (8.3 versus 19.1 percent). There were no significant differences in the incidence of death or major bleeding.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    is approved by the US Food and Drug Administration for prevention of venous thromboembolic disease in patients with hip fracture. It is recommended as an option for first-line prophylactic therapy by guidelines from the ACCP, although more bleeding events were seen with prophylaxis using fondaparinux compared to low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. Bleeding risks with fondaparinux are greater in patients weighing less than 110 lbs (50 kg) and in frail older patients. Additionally, fondaparinux is more costly than other options.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Warfarin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (INR of 1.5) has been compared to placebo in two controlled trials of patients with hip fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Warfarin, at a target INR of 2 to 2.7, has been compared to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/49\">",
"     49",
"    </a>",
"    ]. Warfarin significantly reduces the risk of thromboembolic disease compared with placebo or with aspirin.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    has not been compared directly with low-dose unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    in patients with hip fracture surgery. Based upon studies that have compared heparin with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or placebo, the magnitude of risk reduction with warfarin appears to approach that of low-dose unfractionated heparin.",
"   </p>",
"   <p>",
"    Low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    has been compared with low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    and was less effective than low molecular weight heparin (incidence of deep venous thromboembolism 21 versus 7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/51\">",
"     51",
"    </a>",
"    ]. It should be noted, however, that the target INR for warfarin in this study was only 1.5. Comparison studies using higher targeted INRs are not available. In a systematic review comparing warfarin and low-dose molecular weight heparin in studies including patients undergoing hip or knee arthroplasty (but not hip surgery), low molecular weight heparin was slightly more effective than warfarin in preventing VTE, and there were more bleeding complications with warfarin in extended use (up to six weeks postoperatively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Thus, low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    is more effective than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    but may be less effective than low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    . The need to monitor INR for appropriate treatment with warfarin is a potential drawback. However, patients who wish to avoid the discomfort of a twice daily injection may better tolerate and be more compliant with warfarin than low molecular weight heparin.",
"   </p>",
"   <p>",
"    Based upon the studies reviewed, we recommend a target INR of 2.5. The suggested initial oral dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    is in the range of 2 to 5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for the first two days, with the daily dose subsequently adjusted according to the INR. Initial doses at the lower end of this range are suggested for elderly patients, especially those with nutritional, hepatic, or cardiac impairment. Higher initial (\"loading\") doses of warfarin are not recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link\">",
"     \"Therapeutic use of warfarin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3052178\">",
"    <span class=\"h3\">",
"     Other oral agents",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16118514\">",
"    <span class=\"h4\">",
"     Direct thrombin inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of new small molecule direct thrombin inhibitors are available or in development. These orally-active drugs offer the potential for an effective oral antithrombotic agent that does not need to be monitored. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=see_link\">",
"     \"Anticoagulants other than heparin and warfarin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     Dabigatran etexilate",
"    </a>",
"    , the prodrug of the active compound",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    that binds directly to thrombin, is approved in the US for stroke prevention in atrial fibrillation and in Europe and Canada for prevention of VTE following hip and knee replacement surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Apixiban is also approved in Europe for the prevention of VTE following total knee and hip replacement, but has also not been studied in hip fracture surgery. Both dabigatran and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"     apixaban",
"    </a>",
"    had efficacy and side effects similar to low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    in VTE prophylaxis for hip and knee replacement patients, other than hip fracture surgery, but are not yet approved for hip fracture and side effects in this population are not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3052193\">",
"    <span class=\"h4\">",
"     Direct factor Xa inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;An oral direct factor Xa inhibitor,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    , has not been evaluated for prophylaxis in patients undergoing hip fracture surgery. In patients undergoing total knee or hip arthroplasty, rivaroxaban was associated with more major bleeding than low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Timing and duration of anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate timing and duration of anticoagulation is unclear. The 2012 ACCP anticoagulation guidelines recommend starting low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    either 12 hours or more preoperatively or 12 hours or more postoperatively, rather than within four hours of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. A short-acting anticoagulant, such as low molecular weight heparin, or low-dose unfractionated heparin, is preferable for preoperative initiation.",
"   </p>",
"   <p>",
"    There are few data in patients with hip fracture that address how long anticoagulant therapy should be continued. Two autopsy series suggest that the risk of thromboembolism decreases but still persists after the immediate operative period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. In one study of patients with hip fracture who did not receive antithrombotic prophylaxis, the rate of fatal pulmonary embolism declined from 1 percent at 30 days, to 0.4 percent at 60 days and to 0.2 percent at 90 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/54\">",
"     54",
"    </a>",
"    ]. In a second autopsy series of patients who received prophylactic antithrombotic agents, the majority of fatal pulmonary emboli were observed 30 days or more following fracture repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/55\">",
"     55",
"    </a>",
"    ]. These studies suggest that prolonged prophylaxis might be helpful in some patients.",
"   </p>",
"   <p>",
"    The risks of bleeding from prolonged anticoagulation need to be weighed against the risk of DVT and thromboembolism. A randomized trial compared outcomes of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    given postoperatively for 12 to 23 days, or for 6 to 8 days. The relative risk of venographically documented thrombosis was reduced by 95 percent in the group receiving longer treatment, but this was associated with a trend toward more major bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/56\">",
"     56",
"    </a>",
"    ]. At present, it seems reasonable to continue prophylaxis until the patient is fully ambulatory and to extend prophylaxis further in patients in whom the risk of deep venous thrombosis may be increased (eg, those who experienced prolonged immobility post-repair, patients in whom surgery was delayed, or prior history of thromboembolism). The 2012 guidelines from the American College of Chest Physicians (ACCP) suggest that prophylaxis for thromboembolism be extended up to 35 days, rather than for only 10 to 14 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. A systematic review of thromboprophylaxis for major orthopedic surgery, commissioned by the Agency for Healthcare Research and Quality, concluded that there was insufficient evidence regarding the optimal duration of prophylaxis for hip fracture patients undergoing surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/57\">",
"     57",
"    </a>",
"    ]. The review found that prolonged prophylaxis (&ge;21 days), compared to standard duration (7 to 10 days), decreased the risk for thromboembolic events in patients undergoing total hip replacement but increased the risk for minor bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Antiplatelet agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 10 orthopedic trauma trials found that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    significantly reduced the rate of deep venous thrombosis and pulmonary embolism compared with placebo (OR 0.69 for deep venous thrombosis and 0.40 for pulmonary embolus) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/58\">",
"     58",
"    </a>",
"    ]. However, this reduction was significantly less than for other agents.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one double-blind, randomized controlled trial of 251 hip fracture patients, administration of low molecular weight",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      resulted in a relative risk reduction of 37 percent (95% CI 3.7-59.7 percent) compared with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another trial, 194 patients were randomly assigned to receive",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      or placebo following hip fracture [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/49\">",
"       49",
"      </a>",
"      ]. The incidence of all thromboembolic events in the warfarin group was approximately half that observed in the placebo or aspirin groups (20 percent versus 40.9 and 46 percent for aspirin and placebo respectively).",
"     </li>",
"     <li>",
"      In the largest trial, 13,356 patients with hip fracture were randomly assigned to receive 160 mg of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      or placebo for 35 days after surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/60\">",
"       60",
"      </a>",
"      ]. About three quarters of the patients also received another form of thromboprophylaxis (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or compression stockings). Patients who received aspirin had a significantly lower incidence of symptomatic DVT or pulmonary embolism (1.6 versus 2.5 percent). There was no benefit to aspirin in the subgroup who had received low molecular weight heparin. There was no difference in all cause mortality for any group, and aspirin increased the incidence of bleeding complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    alone provides some, though suboptimal, protection against thromboembolic events after hip fracture. The 2012 ACCP guidelines recommend aspirin as an option for thromboprophylaxis (specifying that there was not total consensus about this), but give preference to the use of low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"     43",
"    </a>",
"    ]. Aspirin, at a dose between 325 and 650 mg per day, is best reserved for use as sole chemoprophylaxis in patients at highest risk for hemorrhagic complications with anticoagulants in whom the risk of bleeding outweighs the benefit of optimal DVT prophylaxis. Such patients should receive concurrent mechanical thromboprophylaxis. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Intermittent leg compression'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Intermittent leg compression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumatic sequential leg compression devices appear to decrease the incidence of postoperative deep vein thrombosis in urological, neurosurgical, and general surgical patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/61\">",
"     61",
"    </a>",
"    ]. A systematic review of five trials with 487 hip surgery patients found lower pooled rates of DVT in patients treated with mechanical pumping devices (7 versus 22 percent), although methodologic flaws in the studies were noted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no randomized trials of the combined use of mechanical and anticoagulant thromboprophylaxis in hip fracture patients, although effectiveness of this approach is suggested by at least one observational study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/62\">",
"     62",
"    </a>",
"    ]. We suggest the routine use of intermittent pneumatic compression devices in addition to anticoagulation until the patient is ambulating on a routine basis. These devices should be used with caution in the elderly delirious patient who may perceive them as a form of restraint, and in whom they may increase the risk for falls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Graduated compression stockings",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective randomized trial of graduated compression stockings, worn for a mean of 42 days, as adjunctive therapy to short-term",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    in 795 patients undergoing hip surgery found no difference in the prevalence of DVT for patients treated with stockings plus fondaparinux versus fondaparinux alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/63\">",
"     63",
"    </a>",
"    ]. While mechanical compression may be of benefit for patients in whom anticoagulation cannot be administered, routine use of graduated compression stockings is both costly and bothersome, and is not recommended for patients who can be treated with anticoagulation postoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DELIRIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delirium is a transient global disorder of cognition characterized by concurrent difficulty with attention, perception, thinking, memory, psychomotor behavior, and the sleep wake cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. It may be the most frequent complication observed in the hospitalized elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/66\">",
"     66",
"    </a>",
"    ]. Delirium occurs in an estimated 11 to 30 percent of elderly general medical patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/67\">",
"     67",
"    </a>",
"    ] and in as many as 61 percent of patients with hip fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/68\">",
"     68",
"    </a>",
"    ]. Despite its prevalence, delirium is often unrecognized or misdiagnosed, particularly in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/67,69\">",
"     67,69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for the development of delirium include advanced age, history of cognitive impairment, preoperative use of psychotropic medication, greater illness severity, sensory impairment, vision impairment, dehydration and electrolyte imbalances, tobacco use, history of vascular surgery, and hip fracture on hospital admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/70-77\">",
"     70-77",
"    </a>",
"    ]. Among 365 patients hospitalized for hip fracture in Norway, independent risk factors for postoperative delirium were cognitive impairment, indoor injury, and low BMI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Common precipitating factors include physical restraints, urinary catheters, iatrogenic medical complications, more than three new medications (",
"    <a class=\"graphic graphic_table graphicRef70449 \" href=\"mobipreview.htm?1/11/1214\">",
"     table 2",
"    </a>",
"    ), and malnutrition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/73\">",
"     73",
"    </a>",
"    ]. In one study, over half of the cases of delirium in patients with hip fracture occurred after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/79\">",
"     79",
"    </a>",
"    ]. Most cases had multifactorial etiologies; the most common causes included",
"    <span class=\"nowrap\">",
"     sensory/environmental,",
"    </span>",
"    infection, drug use, and",
"    <span class=\"nowrap\">",
"     fluid/electrolyte",
"    </span>",
"    disturbance. A systematic review found that regional anesthesia, compared to general anesthesia, was associated with a reduced risk for acute postoperative confusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pain increases the risk of delirium in patients and adequate analgesia can decrease this risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. In a systematic review and meta-analysis including four randomized trials of patients following hip fracture, moderate level evidence indicates that pain control with nerve blockade reduced the risk of delirium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/82\">",
"     82",
"    </a>",
"    ]. Most of the trials included in this meta-analysis used",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    for nerve block. Although opioids produce sedation and may also be associated with delirium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/83\">",
"     83",
"    </a>",
"    ], the beneficial effect of controlling perioperative pain appears to outweigh the risk for most opioids; on balance perioperative opioid use does not increase, and may decrease, the risk of delirium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/81,84\">",
"     81,84",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     Meperidine",
"    </a>",
"    , however, appears to have a particularly strong association with delirium, and should be avoided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/81\">",
"     81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link&amp;anchor=H3#H3\">",
"     \"Prevention and treatment of delirium and confusional states\", section on 'Risk factors and causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another etiology of delirium to be considered is benzodiazepine or alcohol withdrawal in patients with substance dependence prehospitalization. History obtained from the patient or family and physical exam findings can suggest the diagnosis of withdrawal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15577?source=see_link\">",
"     \"Identification and management of alcohol use disorders in the perioperative period\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link\">",
"     \"Prevention and treatment of delirium and confusional states\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delirium in hospitalized patients increases the length of stay, risk of complications, mortality, and institutionalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/85-89\">",
"     85-89",
"    </a>",
"    ]. Delirium in patients with hip fracture can interfere with rehabilitation activities and delay the return to weight bearing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Prevention and management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients who develop delirium have at least some persistent symptoms six months later. Thus, prevention and appropriate treatment of delirium is an important aspect of patient management. Treatment strategies are not as effective as prevention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are four basic principles of delirium prevention and therapy (",
"    <a class=\"graphic graphic_algorithm graphicRef59337 \" href=\"mobipreview.htm?9/29/9682\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link\">",
"     \"Prevention and treatment of delirium and confusional states\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Avoid factors known to cause or aggravate delirium",
"     </li>",
"     <li>",
"      Identify and treat the underlying acute illness",
"     </li>",
"     <li>",
"      Provide supportive and restorative care to prevent further physical and cognitive decline",
"     </li>",
"     <li>",
"      Control dangerous and disruptive behaviors so the first three steps can be accomplished.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early geriatrics consultation may be helpful. A randomized trial of 126 patients over the age of 65 admitted for surgical repair of hip fracture found that proactive geriatrics consultation reduced the risk of delirium compared with usual care (32 versus 50 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/91\">",
"     91",
"    </a>",
"    ]. One case of delirium was prevented for every 5.6 patients in the geriatrics consultation group. Ten components of care were included in the consultation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Adequate oxygen supply for CNS function",
"     </li>",
"     <li>",
"      Fluid and electrolyte balance",
"     </li>",
"     <li>",
"      Treatment of pain",
"     </li>",
"     <li>",
"      Eliminating unnecessary medication",
"     </li>",
"     <li>",
"      Management of bowel and bladder function",
"     </li>",
"     <li>",
"      Adequate nutrition",
"     </li>",
"     <li>",
"      Early mobilization",
"     </li>",
"     <li>",
"      Identify and treat postoperative complications",
"     </li>",
"     <li>",
"      Environmental stimulation",
"     </li>",
"     <li>",
"      Treat agitation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other preventive interventions have been evaluated in nonrandomized studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study compared a multicomponent intervention (geriatric assessment, oxygen therapy for hypoxia, early surgery, and aggressive treatment of perioperative blood pressure falls) in 103 subjects with hip fracture, compared to 111 historical controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/92\">",
"       92",
"      </a>",
"      ]. The incidence of delirium during the first seven postoperative days was 61 and 48 percent in the historical controls and the treatment group, respectively. Subjects in the intervention group were less likely to be confused for more than seven days and had a shorter length of stay.",
"     </li>",
"     <li>",
"      A nursing intervention that included \"preventive measures\" (addressing strange environment, altered sensory input, loss of control and independence, immobility, and disrupted elimination patterns) and \"ameliorative approaches\" (related to mild confusion, sundowning, and unsafe behaviors) decreased the incidence of delirium in the first five postoperative days. Delirium occurred in 44 percent of patients who received the intervention and 52 percent in controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/93\">",
"       93",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other studies of nursing interventions in the medically ill elderly, however, revealed no significant differences in the development of delirium, although one study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/94\">",
"       94",
"      </a>",
"      ] found that the intervention cohort had shorter duration and decreased severity of delirium [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/94-96\">",
"       94-96",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pharmacologic prophylaxis for delirium has not been well studied. One randomized control trial evaluated the use of low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    (1.5",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    in 430 hip surgery patients aged 70 years or older who were at risk for delirium based on visual impairment, cognitive impairment, dehydration, and illness severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/97\">",
"     97",
"    </a>",
"    ]. Haloperidol was started preoperatively and continued for up to three days postoperatively. The incidence of postoperative delirium was not reduced in the treatment group, although haloperidol-treated patients had a decrease in duration of delirium and hospitalization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once delirium has developed, there is little evidence that intervention can improve outcome. A randomized trial to assess the impact of geriatric assessment on the management of delirium in the medically ill elderly found no significant effect on mental status, behavioral assessment, use of restraints, length of stay, discharge site, or mortality rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Low-dose neuroleptics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    ) and occasionally benzodiazepines may be necessary in some patients for prompt symptom control to prevent harm or allow evaluation and treatment. However, benzodiazepines may increase confusion, and most neuroleptics increase risk for extrapyramidal side effects, especially in higher doses and in elderly patients; the atypical antipsychotics",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    may be preferable. All antipsychotics carry a black box warning for an increased risk of arrhythmias and death in older patients, and should be monitored closely. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link&amp;anchor=H13#H13\">",
"     \"Prevention and treatment of delirium and confusional states\", section on 'Medications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients whose delirium interferes with care may benefit from a low-dose neuroleptic (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    0.25 mg to 0.5 mg orally or intravenously every 6 hours,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    0.25 mg to 0.5 mg orally twice a day, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    2.5 mg orally once a day). These drugs should be stopped as soon as the delirium has improved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     OSTEOPOROSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hip fracture is a manifestation of severe osteoporosis. Approximately 20 percent of hip fracture patients will incur another fracture in the next two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/99\">",
"     99",
"    </a>",
"    ]. Physicians and patients need to be educated on the importance of osteoporosis treatment after a hip fracture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link&amp;anchor=H38#H38\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Medical intervention after fracture'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with a recent hip fracture should be evaluated and treated for their underlying osteoporosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/100\">",
"     100",
"    </a>",
"    ]. 2008 guidelines from the National Osteoporosis Foundation recommend pharmacologic intervention for osteoporosis in postmenopausal women and in men who have a history of vertebral fracture, regardless of bone density findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/101\">",
"     101",
"    </a>",
"    ]. Bone densitometry is indicated to establish a baseline to monitor treatment response, but not to determine whether to initiate treatment.",
"   </p>",
"   <p>",
"    Unfortunately, the majority of patients who have had fragility fractures are not evaluated for osteoporosis and do not subsequently receive antiresorptive therapy, which has been shown to reduce the risk of a second fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/102-104\">",
"     102-104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review of 124 women with fragility fractures, over 50 percent were not receiving any treatment for osteoporosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/102\">",
"       102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second community-based study of 60 women over age 65 with a recent hip fracture, only 13 percent were receiving adequate treatment for osteoporosis as defined by the National Osteoporosis Foundation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/103\">",
"       103",
"      </a>",
"      ]. Forty-seven percent of women were receiving inadequate treatment and 40 percent were receiving no treatment at all.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been recommended that hip fracture patients maintain an adequate intake of calcium (1200 mg daily minimum) and vitamin D (400 to 800 IU daily) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/100\">",
"     100",
"    </a>",
"    ]. However, two randomized trials found no significant effect for calcium and vitamin D in fracture prevention for high risk patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/105\">",
"     105",
"    </a>",
"    ] or patients with history of hip fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bisphosphonates are considered first line drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/107\">",
"     107",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intravenous bisphosphonates can cause serious hypocalcemia in vitamin D deficient patients; the incidence of vitamin D deficiency in hip fracture patients may exceed 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized trial compared annual",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    infusion (5 mg) versus placebo, initiated within 90 days of surgical hip repair, in a population of 2100 patients who had refused or been intolerant of oral bisphosphonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/109\">",
"     109",
"    </a>",
"    ]. At median follow-up of 1.9 years, patients treated with zoledronic acid, compared to placebo, had lower rates for overall fractures (8.6 versus 13.9 percent) and decreased mortality (9.6 versus 13.3 percent), although rates of second hip fractures (2.0 versus 3.5 percent) were not significantly reduced. All patients received a loading dose of 100,000 to 125,000 units of vitamin D at least one week prior to zoledronic acid infusion. Patients also received ongoing calcium and vitamin D supplementation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     OTHER ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other issues that arise in patients with hip fracture include nutritional management, prevention of pressure ulcers, urinary tract management, management of anemia, and assessment of fall risk. Additionally, hip fracture patients have a high risk for 28-day readmission following hospital discharge.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Attention should be paid to prevent constipation, especially in patients who receive opioid analgesics. Stool softeners and prokinetic agents, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40276?source=see_link\">",
"       senna",
"      </a>",
"      compounds, may be helpful. Peripherally-active opioid antagonists (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/7/5236?source=see_link\">",
"       alvimopan",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/29/2516?source=see_link\">",
"       methylnaltrexone",
"      </a>",
"      ) may be helpful [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/110\">",
"       110",
"      </a>",
"      ]. Patients who are eating and have not had a bowel movement in two days should be treated with gentle laxative therapy (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6213?source=see_link\">",
"       bisacodyl",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/14/39140?source=see_link\">",
"       magnesium citrate",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/6/31847?source=see_link\">",
"       magnesium hydroxide",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2586?source=see_link\">",
"       \"Postoperative ileus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link\">",
"       \"Management of chronic constipation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oral nutritional supplementation (eg, Ensure&trade; or Sustacal&trade;, one can three times daily between meals) may be beneficial for reducing minor postoperative complications in patients with hip fracture, preserving body protein stores, and reducing the overall length of stay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/111-114\">",
"       111-114",
"      </a>",
"      ], although a systematic review found only weak evidence based on trials with methodologic flaws [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/114\">",
"       114",
"      </a>",
"      ]. Nocturnal enteral feeding should be considered for patients with moderate to severe malnutrition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/115\">",
"       115",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33592?source=see_link\">",
"       \"Enteral feeding: Gastric versus post-pyloric\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/17/34073?source=see_link\">",
"       \"Nutrition support in critically ill patients: Enteral nutrition\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pressure ulcers occur in 10 to 40 percent of patients hospitalized for hip fracture, and increase nosocomial infection rates and lengths of stay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/116\">",
"       116",
"      </a>",
"      ]. The incidence of pressure ulcers was greater during the acute hospital period than in the subsequent rehabilitation or nursing home setting over a period of 32 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/117\">",
"       117",
"      </a>",
"      ]. Use of foam or alternating pressure mattresses, compared with usual care, reduce the incidence of pressure ulcers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/116\">",
"       116",
"      </a>",
"      ]. In one report, as an example, a six-inch deep foam mattress reduced the incidence of pressure ulcers among elderly patients with hip fractures from 68 to 24 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/118\">",
"       118",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/1/1049?source=see_link\">",
"       \"Prevention of pressure ulcers\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Short-term use of indwelling urinary catheters appears to reduce the incidence of urinary retention and bladder overdistention compared with intermittent catheterization alone, without increasing the rate of urinary tract infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/119\">",
"       119",
"      </a>",
"      ]. Catheters should be removed within 24 hours of surgery to prevent iatrogenic urinary infection; patients can be managed subsequently with intermittent catheterization if needed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/119-121\">",
"       119-121",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link\">",
"       \"Urinary tract infection associated with urethral catheters\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The optimal threshold for postoperative transfusion was evaluated in a randomized trial that found similar outcomes (mortality, ambulatory status at 60 days, and cardiovascular events) for postoperative hip fracture patients who received either liberal transfusion (maintaining hemoglobin &gt;10",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      or",
"      <span class=\"nowrap\">",
"       symptomatic/restrictive",
"      </span>",
"      transfusion (transfusion for symptoms or when hemoglobin fell below 8",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/122\">",
"       122",
"      </a>",
"      ]. Results of this study suggest that it is reasonable to withhold transfusion in patients who have undergone surgery in the absence of symptoms of anemia or in the absence of a decline in the hemoglobin level below 8",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      even in older patients with underlying cardiovascular disease or cardiovascular risk factors. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/52/5961?source=see_link&amp;anchor=H6#H6\">",
"       \"Indications for red cell transfusion in the adult\", section on 'Patients with cardiovascular disease or risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with hip fractures are at increased risk for a second fracture; risk of a second fracture is greater for older patients and patients who have a higher functional level [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/123\">",
"       123",
"      </a>",
"      ]. Treatment with vitamin D is recommended to reduce fall risk and subsequent fracture in patients who have sustained a hip fracture [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/124,125\">",
"       124,125",
"      </a>",
"      ]. Vitamin D (2000 units daily) may also reduce rate of hospital readmission in patients following hip fracture [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/126\">",
"       126",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/21/3417?source=see_link\">",
"       \"Treatment of vitamin D deficiency in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A retrospective study of hip fracture patients in England found a 28-day readmission rate of 11.8 percent, with risk particularly increased in patients with comorbidities such as diabetes or neurologic disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/127\">",
"       127",
"      </a>",
"      ]. Whether multidisciplinary postoperative management for such patients reduces the risk of rehospitalization is not established, but may be helpful. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11417?source=see_link&amp;anchor=H30994487#H30994487\">",
"       \"Managing multiple comorbidities\", section on 'Coordination of care'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence-based guidelines for the management of hip fracture are available from the United Kingdom [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/128\">",
"     128",
"    </a>",
"    ], New Zealand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/129\">",
"     129",
"    </a>",
"    ], and Australia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/58/33706/abstract/130\">",
"     130",
"    </a>",
"    ]. Recommendations in these guidelines largely support the discussion presented in this topic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/33/14867?source=see_link\">",
"       \"Patient information: Hip fracture (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend that hip fracture surgery be performed within 48 hours of hospitalization for patients who are medically stable and without significant comorbid illness (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Whenever possible, surgery should not be delayed beyond 72 hours. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Timing of surgical intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend use of prophylactic antistaphylococcal antibiotics (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We suggest that antibiotics be initiated within two hours prior to surgery and continued to provide antibiotic concentrations for 24 hours after surgery (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). A reasonable choice is a first generation cephalosporin (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"       cefazolin",
"      </a>",
"      1 to 2 g intravenously Q 8 hours for three doses) for hospitals where methicillin resistance is not prevalent;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (1 g intravenously Q 12 hours) is advised for patients allergic to penicillins or in hospitals with high rates of methicillin-resistant organisms. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Prophylactic antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend thromboembolic prophylaxis for patients hospitalized with hip fracture (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We suggest low molecular weight",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      at high doses (&gt;3400 units daily or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"       enoxaparin",
"      </a>",
"      30 mg every 12 hours or 40 mg once daily) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Alternative regimens are low-dose unfractionated heparin (5000 units twice daily),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      (2.5 mg once daily), or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      with a target INR of 2.5. We suggest pneumatic leg compression as an adjunct to anticoagulation until the patient is regularly ambulatory (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Thromboembolic prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest initiating thromboembolic prophylaxis with a short-acting anticoagulant (eg, low molecular weight or low-dose unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      ) either 12 hours or more preoperatively, or using any of the above regimens 12 hours or more postoperatively (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest that thromboembolic prophylaxis be continued for at least 10 to 14 days post-operatively and until the patient is fully ambulatory (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); patients at high risk for DVT may require a longer course of anticoagulation. Patients at increased risk include those who experienced prolonged immobility post-repair, patients in whom surgery was delayed, or prior history of thromboembolism. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Timing and duration of anticoagulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not prescribing postoperative graduated compression stockings for routine postoperative use (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Graduated compression stockings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with hip fracture are at high risk for postoperative delirium. Underlying precipitating factors should be treated. The benefits of most opioid analgesics in achieving pain control outweigh risks for most patients.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"       Meperidine",
"      </a>",
"      has a particularly strong association with delirium and should not be prescribed. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Prevention and management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest treatment with a low dose of a neuroleptic (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"       haloperidol",
"      </a>",
"      0.25 mg to 0.5 mg orally or intravenously every six hours,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      0.25 mg to 0.5 mg orally twice a day, or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"       olanzapine",
"      </a>",
"      2.5 mg orally once a day) for patients whose agitated delirium interferes with care (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); neuroleptics should be stopped as soon as the delirium has improved. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Delirium'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a recent hip fracture should be evaluated with bone densitometry for underlying osteoporosis. Regardless of bone density results, hip fracture patients should be treated with bisphosphonate therapy for osteoporosis. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Osteoporosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Available at: www.ahrq.gov/data/hcup (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/2\">",
"      Hung WW, Egol KA, Zuckerman JD, Siu AL. Hip fracture management: tailoring care for the older patient. JAMA 2012; 307:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/3\">",
"      Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009; 302:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/4\">",
"      Haentjens P, Magaziner J, Col&oacute;n-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010; 152:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/5\">",
"      Magaziner J, Simonsick EM, Kashner TM, et al. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol 1990; 45:M101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/6\">",
"      French DD, Bass E, Bradham DD, et al. Rehospitalization after hip fracture: predictors and prognosis from a national veterans study. J Am Geriatr Soc 2008; 56:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/7\">",
"      Boockvar KS, Halm EA, Litke A, et al. Hospital readmissions after hospital discharge for hip fracture: surgical and nonsurgical causes and effect on outcomes. J Am Geriatr Soc 2003; 51:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/8\">",
"      Morrison RS, Chassin MR, Siu AL. The medical consultant's role in caring for patients with hip fracture. Ann Intern Med 1998; 128:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/9\">",
"      Adams AL, Schiff MA, Koepsell TD, et al. Physician consultation, multidisciplinary care, and 1-year mortality in Medicare recipients hospitalized with hip and lower extremity injuries. J Am Geriatr Soc 2010; 58:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/10\">",
"      Zuckerman JD. Hip fracture. N Engl J Med 1996; 334:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/11\">",
"      Hamlet WP, Lieberman JR, Freedman EL, et al. Influence of health status and the timing of surgery on mortality in hip fracture patients. Am J Orthop (Belle Mead NJ) 1997; 26:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/12\">",
"      Kenzora JE, McCarthy RE, Lowell JD, Sledge CB. Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications. Clin Orthop Relat Res 1984; :45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/13\">",
"      Ho V, Hamilton BH, Roos LL. Multiple approaches to assessing the effects of delays for hip fracture patients in the United States and Canada. Health Serv Res 2000; 34:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/14\">",
"      Hamilton BH, Hamilton VH, Mayo NE. What are the costs of queuing for hip fracture surgery in Canada? J Health Econ 1996; 15:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/15\">",
"      Dolk T. Operation in hip fracture patients--analysis of the time factor. Injury 1990; 21:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/16\">",
"      Davis TR, Sher JL, Porter BB, Checketts RG. The timing of surgery for intertrochanteric femoral fractures. Injury 1988; 19:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/17\">",
"      Hoenig H, Rubenstein LV, Sloane R, et al. What is the role of timing in the surgical and rehabilitative care of community-dwelling older persons with acute hip fracture? Arch Intern Med 1997; 157:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/18\">",
"      Davis FM, Woolner DF, Frampton C, et al. Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth 1987; 59:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/19\">",
"      Bredahl C, Nyholm B, Hindsholm KB, et al. Mortality after hip fracture: results of operation within 12 h of admission. Injury 1992; 23:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/20\">",
"      Rogers FB, Shackford SR, Keller MS. Early fixation reduces morbidity and mortality in elderly patients with hip fractures from low-impact falls. J Trauma 1995; 39:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/21\">",
"      Zuckerman JD, Skovron ML, Koval KJ, et al. Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip. J Bone Joint Surg Am 1995; 77:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/22\">",
"      Grimes JP, Gregory PM, Noveck H, et al. The effects of time-to-surgery on mortality and morbidity in patients following hip fracture. Am J Med 2002; 112:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/23\">",
"      Orosz GM, Magaziner J, Hannan EL, et al. Association of timing of surgery for hip fracture and patient outcomes. JAMA 2004; 291:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/24\">",
"      Bottle A, Aylin P. Mortality associated with delay in operation after hip fracture: observational study. BMJ 2006; 332:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/25\">",
"      Vid&aacute;n MT, S&aacute;nchez E, Gracia Y, et al. Causes and effects of surgical delay in patients with hip fracture: a cohort study. Ann Intern Med 2011; 155:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/26\">",
"      Simunovic N, Devereaux PJ, Sprague S, et al. Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ 2010; 182:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/27\">",
"      Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth 2008; 55:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/28\">",
"      McLaughlin MA, Orosz GM, Magaziner J, et al. Preoperative status and risk of complications in patients with hip fracture. J Gen Intern Med 2006; 21:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/29\">",
"      Bodoky A, Neff U, Heberer M, Harder F. Antibiotic prophylaxis with two doses of cephalosporin in patients managed with internal fixation for a fracture of the hip. J Bone Joint Surg Am 1993; 75:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/30\">",
"      Buckley R, Hughes GN, Snodgrass T, Huchcroft SA. Perioperative cefazolin prophylaxis in hip fracture surgery. Can J Surg 1990; 33:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/31\">",
"      Tengve B, Kjellander J. Antibiotic prophylaxis in operations on trochanteric femoral fractures. J Bone Joint Surg Am 1978; 60:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/32\">",
"      McQueen MM, LittleJohn MA, Miles RS, Hughes SP. Antibiotic prophylaxis in proximal femoral fracture. Injury 1990; 21:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/33\">",
"      Ericson C, Lidgren L, Lindberg L. Cloxacillin in the prophylaxis of postoperative infections of the hip. J Bone Joint Surg Am 1973; 55:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/34\">",
"      Boyd RJ, Burke JF, Colton T. A double-blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg Am 1973; 55:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/35\">",
"      Hjortrup A, S&oslash;rensen C, Mejdahl S, et al. Antibiotic prophylaxis in surgery for hip fractures. Acta Orthop Scand 1990; 61:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/36\">",
"      Gillespie WJ, Walenkamp G. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev 2001; :CD000244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/37\">",
"      Southwell-Keely JP, Russo RR, March L, et al. Antibiotic prophylaxis in hip fracture surgery: a metaanalysis. Clin Orthop Relat Res 2004; :179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/38\">",
"      Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/39\">",
"      Boxma H, Broekhuizen T, Patka P, Oosting H. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet 1996; 347:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/40\">",
"      Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2012; 10:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/41\">",
"      Merrer J, Girou E, Lortat-Jacob A, et al. Surgical site infection after surgery to repair femoral neck fracture: a French multicenter retrospective study. Infect Control Hosp Epidemiol 2007; 28:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/42\">",
"      Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:338S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/43\">",
"      Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e278S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/44\">",
"      Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/45\">",
"      Nightingale SL. From the Food and Drug Administration. JAMA 1998; 279:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/46\">",
"      Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/47\">",
"      Handoll HH, Farrar MJ, McBirnie J, et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 2002; :CD000305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/48\">",
"      Eriksson BI, Bauer KA, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/49\">",
"      Powers PJ, Gent M, Jay RM, et al. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 1989; 149:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/50\">",
"      Morris GK, Mitchell JR. Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 1976; 2:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/51\">",
"      Gerhart TN, Yett HS, Robertson LK, et al. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial. J Bone Joint Surg Am 1991; 73:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/52\">",
"      Eriksson BI, Dahl OE, B&uuml;ller HR, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005; 3:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/53\">",
"      Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007; 370:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/54\">",
"      Schr&oslash;der HM, Andreassen M. Autopsy-verified major pulmonary embolism after hip fracture. Clin Orthop Relat Res 1993; :196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/55\">",
"      Bergqvist D, Fredin H. Pulmonary embolism and mortality in patients with fractured hips--a prospective consecutive series. Eur J Surg 1991; 157:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/56\">",
"      Eriksson BI, Lassen MR, PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003; 163:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/57\">",
"      Sobieraj DM, Lee S, Coleman CI, et al. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med 2012; 156:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/58\">",
"      Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994; 308:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/59\">",
"      Gent M, Hirsh J, Ginsberg JS, et al. Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation 1996; 93:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/60\">",
"      Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/61\">",
"      Coe NP, Collins RE, Klein LA, et al. Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots. Surgery 1978; 83:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/62\">",
"      Westrich GH, Rana AJ, Terry MA, et al. Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. J Orthop Trauma 2005; 19:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/63\">",
"      Cohen AT, Skinner JA, Warwick D, Brenkel I. The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study. J Bone Joint Surg Br 2007; 89:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/64\">",
"      Lipowski ZJ. Delirium in the elderly patient. N Engl J Med 1989; 320:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/65\">",
"      Lipowski ZJ. Transient cognitive disorders (delirium, acute confusional states) in the elderly. Am J Psychiatry 1983; 140:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/66\">",
"      Gillick MR, Serrell NA, Gillick LS. Adverse consequences of hospitalization in the elderly. Soc Sci Med 1982; 16:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/67\">",
"      Rummans TA, Evans JM, Krahn LE, Fleming KC. Delirium in elderly patients: evaluation and management. Mayo Clin Proc 1995; 70:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/68\">",
"      Gustafson Y, Berggren D, Br&auml;nnstr&ouml;m B, et al. Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc 1988; 36:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/69\">",
"      Inouye SK. Delirium in older persons. N Engl J Med 2006; 354:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/70\">",
"      Foreman MD. Confusion in the hospitalized elderly: incidence, onset, and associated factors. Res Nurs Health 1989; 12:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/71\">",
"      Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990; 263:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/72\">",
"      Inouye SK, Viscoli CM, Horwitz RI, et al. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/73\">",
"      Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996; 275:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/74\">",
"      Marcantonio ER, Goldman L, Mangione CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994; 271:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/75\">",
"      Kalisvaart KJ, Vreeswijk R, de Jonghe JF, et al. Risk factors and prediction of postoperative delirium in elderly hip-surgery patients: implementation and validation of a medical risk factor model. J Am Geriatr Soc 2006; 54:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/76\">",
"      Dasgupta M, Dumbrell AC. Preoperative risk assessment for delirium after noncardiac surgery: a systematic review. J Am Geriatr Soc 2006; 54:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/77\">",
"      Rudolph JL, Jones RN, Rasmussen LS, et al. Independent vascular and cognitive risk factors for postoperative delirium. Am J Med 2007; 120:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/78\">",
"      Julieb&oslash; V, Bj&oslash;ro K, Krogseth M, et al. Risk factors for preoperative and postoperative delirium in elderly patients with hip fracture. J Am Geriatr Soc 2009; 57:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/79\">",
"      Brauer C, Morrison RS, Silberzweig SB, Siu AL. The cause of delirium in patients with hip fracture. Arch Intern Med 2000; 160:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/80\">",
"      Parker MJ, Handoll HH, Griffiths R. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2004; :CD000521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/81\">",
"      Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003; 58:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/82\">",
"      Abou-Setta AM, Beaupre LA, Rashiq S, et al. Comparative effectiveness of pain management interventions for hip fracture: a systematic review. Ann Intern Med 2011; 155:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/83\">",
"      Schor JD, Levkoff SE, Lipsitz LA, et al. Risk factors for delirium in hospitalized elderly. JAMA 1992; 267:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/84\">",
"      Lynch EP, Lazor MA, Gellis JE, et al. The impact of postoperative pain on the development of postoperative delirium. Anesth Analg 1998; 86:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/85\">",
"      Cole MG, Primeau F, McCusker J. Effectiveness of interventions to prevent delirium in hospitalized patients: a systematic review. CMAJ 1996; 155:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/86\">",
"      Francis J, Kapoor WN. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 1992; 40:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/87\">",
"      Levkoff SE, Evans DA, Liptzin B, et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992; 152:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/88\">",
"      Murray AM, Levkoff SE, Wetle TT, et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 1993; 48:M181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/89\">",
"      Rockwood K. Delays in the discharge of elderly patients. J Clin Epidemiol 1990; 43:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/90\">",
"      Milisen K, Lemiengre J, Braes T, Foreman MD. Multicomponent intervention strategies for managing delirium in hospitalized older people: systematic review. J Adv Nurs 2005; 52:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/91\">",
"      Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001; 49:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/92\">",
"      Gustafson Y, Br&auml;nnstr&ouml;m B, Berggren D, et al. A geriatric-anesthesiologic program to reduce acute confusional states in elderly patients treated for femoral neck fractures. J Am Geriatr Soc 1991; 39:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/93\">",
"      Williams MA, Campbell EB, Raynor WJ, et al. Reducing acute confusional states in elderly patients with hip fractures. Res Nurs Health 1985; 8:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/94\">",
"      Milisen K, Foreman MD, Abraham IL, et al. A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. J Am Geriatr Soc 2001; 49:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/95\">",
"      Nagley SJ. Predicting and preventing confusion in your patients. J Gerontol Nurs 1986; 12:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/96\">",
"      Wanich CK, Sullivan-Marx EM, Gottlieb GL, Johnson JC. Functional status outcomes of a nursing intervention in hospitalized elderly. Image J Nurs Sch 1992; 24:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/97\">",
"      Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005; 53:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/98\">",
"      Cole MG, Primeau FJ, Bailey RF, et al. Systematic intervention for elderly inpatients with delirium: a randomized trial. CMAJ 1994; 151:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/99\">",
"      Col&oacute;n-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 2003; 14:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/100\">",
"      Freitag MH, Magaziner J. Post-operative considerations in hip fracture management. Curr Rheumatol Rep 2006; 8:55.",
"     </a>",
"    </li>",
"    <li>",
"     National Osteoporosis Foundation. NOF's Clincian's Guide to Prevention and Treatment of Osteoporosis www.nof.org/professionals/clinicians_guide.htm (Accessed on August 13, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/102\">",
"      Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998; 57:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/103\">",
"      Bellantonio S, Fortinsky R, Prestwood K. How well are community-living women treated for osteoporosis after hip fracture? J Am Geriatr Soc 2001; 49:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/104\">",
"      Harrington JT, Broy SB, Derosa AM, et al. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 2002; 47:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/105\">",
"      Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005; 330:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/106\">",
"      Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/107\">",
"      North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause 2006; 13:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/108\">",
"      Pieper CF, Colon-Emeric C, Caminis J, et al. Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture. Am J Geriatr Pharmacother 2007; 5:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/109\">",
"      Lyles KW, Col&oacute;n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007; 357:1799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/110\">",
"      Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs 2007; 16:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/111\">",
"      Tkatch L, Rapin CH, Rizzoli R, et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992; 11:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/112\">",
"      Delmi M, Rapin CH, Bengoa JM, et al. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet 1990; 335:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/113\">",
"      Stableforth PG. Supplement feeds and nitrogen and calorie balance following femoral neck fracture. Br J Surg 1986; 73:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/114\">",
"      Avenell A, Handoll HH. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2010; :CD001880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/115\">",
"      Bastow MD, Rawlings J, Allison SP. Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. Br Med J (Clin Res Ed) 1983; 287:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/116\">",
"      Beaupre LA, Jones CA, Saunders LD, et al. Best practices for elderly hip fracture patients. A systematic overview of the evidence. J Gen Intern Med 2005; 20:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/117\">",
"      Baumgarten M, Margolis DJ, Orwig DL, et al. Pressure ulcers in elderly patients with hip fracture across the continuum of care. J Am Geriatr Soc 2009; 57:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/118\">",
"      Hofman A, Geelkerken RH, Wille J, et al. Pressure sores and pressure-decreasing mattresses: controlled clinical trial. Lancet 1994; 343:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/119\">",
"      Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-replacement surgery. N Engl J Med 1988; 319:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/120\">",
"      Skelly JM, Guyatt GH, Kalbfleisch R, et al. Management of urinary retention after surgical repair of hip fracture. CMAJ 1992; 146:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/121\">",
"      Johansson I, Athlin E, Frykholm L, et al. Intermittent versus indwelling catheters for older patients with hip fractures. J Clin Nurs 2002; 11:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/122\">",
"      Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/123\">",
"      Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med 2007; 167:1971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/124\">",
"      Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293:2257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/125\">",
"      Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007; 55:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/126\">",
"      Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 2010; 170:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/127\">",
"      Khan MA, Hossain FS, Dashti Z, Muthukumar N. Causes and predictors of early re-admission after surgery for a fracture of the hip. J Bone Joint Surg Br 2012; 94:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/128\">",
"      Ftouh S, Morga A, Swift C, Guideline Development Group. Management of hip fracture in adults: summary of NICE guidance. BMJ 2011; 342:d3304.",
"     </a>",
"    </li>",
"    <li>",
"     www.nzgg.org.nz/guidelines/0007/ACF420.pdf (Accessed on August 08, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/58/33706/abstract/130\">",
"      Chilov MN, Cameron ID, March LM, Australian National Health and Medical Research Council. Evidence-based guidelines for fixing broken hips: an update. Med J Aust 2003; 179:489.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4813 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-B1A854215F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33706=[""].join("\n");
var outline_f32_58_33706=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TIMING OF SURGICAL INTERVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Preoperative morbidity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PROPHYLACTIC ANTIBIOTICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Efficacy of antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Timing of administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Choice of agent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      THROMBOEMBOLIC PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Anticoagulant therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16118359\">",
"      - Low molecular weight heparin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3052013\">",
"      - Unfractionated heparin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Fondaparinux",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Warfarin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3052178\">",
"      - Other oral agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H16118514\">",
"      Direct thrombin inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3052193\">",
"      Direct factor Xa inhibitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Timing and duration of anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Antiplatelet agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Intermittent leg compression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Graduated compression stockings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DELIRIUM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Prevention and management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      OSTEOPOROSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      OTHER ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/4813\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/4813|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?9/29/9682\" title=\"algorithm 1\">",
"      Assessment and Rx of delirium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/4813|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/6/1132\" title=\"table 1\">",
"      Causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/11/1214\" title=\"table 2\">",
"      Drugs that cause or prolong delirium",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28218?source=related_link\">",
"      Activated protein C resistance and factor V Leiden",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=related_link\">",
"      Anticoagulants other than heparin and warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/51/33592?source=related_link\">",
"      Enteral feeding: Gastric versus post-pyloric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1162?source=related_link\">",
"      Evaluation of preoperative pulmonary risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/31/18937?source=related_link\">",
"      Hip fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15577?source=related_link\">",
"      Identification and management of alcohol use disorders in the perioperative period",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/52/5961?source=related_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/59/43961?source=related_link\">",
"      Low molecular weight heparin for venous thromboembolic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=related_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11417?source=related_link\">",
"      Managing multiple comorbidities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/17/34073?source=related_link\">",
"      Nutrition support in critically ill patients: Enteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/33/14867?source=related_link\">",
"      Patient information: Hip fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/0/18440?source=related_link\">",
"      Perioperative heart failure in noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2586?source=related_link\">",
"      Postoperative ileus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=related_link\">",
"      Prevention and treatment of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/1/1049?source=related_link\">",
"      Prevention of pressure ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/23/44408?source=related_link\">",
"      Therapeutic use of fondaparinux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=related_link\">",
"      Therapeutic use of heparin and low molecular weight heparin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=related_link\">",
"      Treatment of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/21/3417?source=related_link\">",
"      Treatment of vitamin D deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_58_33707="Bleeding risk index warfarin";
var content_f32_58_33707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Index for predicting risk of bleeding with warfarin",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        This index was derived from a retrospective",
"analysis of the incidence of bleeding in 556 outpatients treated with",
"warfarin. There are four adverse risk factors. One point is given for",
"the presence of each of these risk factors, for a total potential score",
"from zero to four.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Age &ge;65 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        History of stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        History of gastrointestinal bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        One or more of the following co-morbid conditions:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Recent myocardial infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Hematocrit &lt;30 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Serum creatinine concentration &gt;1.5 mg/dL (&gt;133 &micro;mol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In the prospective validation portion of this",
"study, the cumulative incidence of major bleeding after 48 months of",
"treatment with warfarin in 264 outpatients was, as follows:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Low risk",
"        </strong>",
"        (no risk factors present, point score 0): 3 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Intermediate risk",
"        </strong>",
"        (point score 1 to 2): 12 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         High risk",
"        </strong>",
"        (point score 3 to 4): 53 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Beyth RJ, et al. Am J Med 1998; 105:91.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33707=[""].join("\n");
var outline_f32_58_33707=null;
var title_f32_58_33708="Lab tests in iron deficiency";
var content_f32_58_33708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F76236&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F76236&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory tests in iron deficiency of increasing severity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Normal",
"       </td>",
"       <td class=\"subtitle1\">",
"        Iron&nbsp;deficiency without anemia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Iron&nbsp;deficiency with mild anemia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severe&nbsp;iron deficiency with severe anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marrow reticulo- endothelial iron",
"       </td>",
"       <td>",
"        <strong>",
"         2+ to 3+",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         None",
"        </strong>",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum iron (SI), &micro;g/dL",
"       </td>",
"       <td>",
"        60 to 150",
"       </td>",
"       <td>",
"        60 to 150",
"       </td>",
"       <td>",
"        <strong>",
"         &lt;60",
"        </strong>",
"       </td>",
"       <td>",
"        &lt;40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total iron binding capacity (transferrin, TIBC), &micro;g/dL",
"       </td>",
"       <td>",
"        300 to 360",
"       </td>",
"       <td>",
"        300 to 390",
"       </td>",
"       <td>",
"        350 to 400",
"       </td>",
"       <td>",
"        <strong>",
"         &gt;410",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transferrin saturation (SI/TIBC), percent",
"       </td>",
"       <td>",
"        20 to 50",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        <strong>",
"         &lt;15",
"        </strong>",
"       </td>",
"       <td>",
"        &lt;10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemoglobin, g/dL",
"       </td>",
"       <td>",
"        <strong>",
"         Normal",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         Normal",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         9 to 12",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         6 to 7",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Red cell morphology",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or slight hypochromia",
"       </td>",
"       <td>",
"        Hypochromia and microcytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasma or serum ferritin, ng/mL",
"       </td>",
"       <td>",
"        40 to 200",
"       </td>",
"       <td>",
"        <strong>",
"         &lt;40",
"        </strong>",
"       </td>",
"       <td>",
"        &lt;20",
"       </td>",
"       <td>",
"        &lt;10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythrocyte protoporphyrin, ng/mL RBC",
"       </td>",
"       <td>",
"        30 to 70",
"       </td>",
"       <td>",
"        30 to 70",
"       </td>",
"       <td>",
"        <strong>",
"         &gt;100",
"        </strong>",
"       </td>",
"       <td>",
"        100 to 200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other tissue changes",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Nail and epithelial changes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: Test results outlined in bold type are the ones most likely to define the various stages of iron deficiency. Thus, the presence or absence of iron stores (marrow reticuloendothelial iron) in a non-anemic patient serves to distinguish normal subjects from those with iron deficiency without anemia, respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33708=[""].join("\n");
var outline_f32_58_33708=null;
var title_f32_58_33709="Contents: Fetoplacental physiology";
var content_f32_58_33709=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Fetoplacental physiology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Fetoplacental physiology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Amniotic fluid",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/52/31558\">",
"           Assessment of amniotic fluid volume",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/55/888\">",
"           Physiology of amniotic fluid volume regulation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fetal membranes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/10/43175\">",
"           Fetal membranes: Anatomy and biochemistry",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Placenta",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/56/40840\">",
"           Gross examination of the placenta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/46/27370\">",
"           Histopathology of placental disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/18/41256\">",
"           Placental development and physiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/26/21929\">",
"           Placental pathology in cases of neurologically impaired infants",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3E3CB8B1B2-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f32_58_33709=[""].join("\n");
var outline_f32_58_33709=null;
var title_f32_58_33710="ACEI delays moderately increased albuminuria";
var content_f32_58_33710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F80409%7ENEPH%2F60878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F80409%7ENEPH%2F60878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Captopril delays progression of moderately increased albuminuria (formerly called microalbuminuria) in diabetes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 250px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect of captopril or placebo in 225 patients with type 1 diabetes mellitus, normal blood pressure, and moderately increased albuminuria (formerly called microalbuminuria). At two years, captopril slowed the rate of progression to overt, dipstick-positive proteinuria and lowered the albumin excretion rate (AER) compared to placebo.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from The Microalbuminuria Study Group, Diabetologia 1996; 39:587.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ACE inhibitor slows progression of diabetic nephropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 255px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The effect of the administration of placebo or captopril to patients with type 1 diabetes with overt proteinuria and a plasma creatinine concentration equal to or greater than 1.5 mg/dL (132 &micro;mol/L). The likelihood of a doubling of the plasma creatinine concentration (Pcr) was reduced by more than 50 percent in the captopril group.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Lewis EJ, Hunsicker LG, Bain RP,&nbsp;et al.&nbsp;N Engl J Med 1993; 329:1456.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33710=[""].join("\n");
var outline_f32_58_33710=null;
var title_f32_58_33711="Chronic EAA CT";
var content_f32_58_33711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic phase of hypersensitivity pneumonitis (extrinsic allergic alveolitis) due to birds. Focal honeycombing is present in the right upper lobe and mild bilateral cylindrical bronchiectasis is visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_58_33711=[""].join("\n");
var outline_f32_58_33711=null;
